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ABSTRACT 
KATHRYN A. COLE: Adipose Tissue Inflammation Is Associated With Immune 
Dysfunction During Influenza Virus Infection  
 (Under the direction of Melinda A. Beck, Ph.D.) 
 
 
 Adipose tissue in the obese state expresses increased concentrations of inflammatory 
mediators and has an increased number of macrophages and T lymphocytes. This raises 
questions about the role that adipose tissue plays during an infectious disease. This 
dissertation describes research in diet-induced obese mice that 1) provides a timeline of 
changes in body composition, hormonal and metabolic alterations, and the onset of 
inflammation in the liver and three adipose tissue depots; and 2) demonstrates that during an 
infectious disease, distant adipose tissue depots undergo changes in their inflammatory state 
and number of leukocytes. A third, conceptually distinct part of this dissertation is the study 
of a mechanism linking preadipocyte proliferation with differentiation. 
 The differentiation of preadipocytes contributes to increased adipose tissue mass through 
increased capacity to store triacylglycerol. Differentiation-induced 3T3-L1 preadipocytes 
undergo several rounds of mitotic clonal expansion while concurrently initiating a cascade of 
transcription factor expression that culminates in the adipocyte phenotype. We demonstrated 
that G1 of the cell cycle and the initiation of differentiation are functionally linked by the 
interaction of hypophosphorylated Rb and C/EBPβ. 
 In order to establish a timeline of the development of inflammation in diet-induced 
obesity, weanling C57BL/6 mice were fed either a low-fat or a high-fat diet for 16 weeks. 
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Our data show that the inflammatory state in adipose tissue is depot-specific, and occurs 
prior to the development of liver steatosis, and increased fasting serum leptin and insulin 
concentrations. 
 Previous work in our laboratory demonstrated that compared to lean mice, diet-induced 
obese mice have higher morbidity and mortality after influenza virus infection. We 
demonstrate that during influenza A/PR/8/34 virus infection, relative to lean mice, adipose 
tissues in obese mice have a greater pro-inflammatory cytokine and chemokine gene 
expression, with a decrease in the number of macrophages and T lymphocytes in the gonadal 
adipose tissue depot. 
 Taken together, our studies demonstrate that obesity can have a profound influence on the 
immune response to an infectious disease and that adipose tissue itself may be a major 
component of the dysregulated immune response during influenza infection.  
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A. Public health impact of obesity   
 Obesity is a complex disease that involves environmental, genetic, physiologic, metabolic 
and psychological components. Worldwide, obesity affects 300 million adults. In the U.S., 
approximately 127 million adults are overweight, 60 million are obese, and 9 million are 
severely obese [1]. Body mass index (BMI), expressed as weight/height2 (BMI; kg/m2), is 
commonly used to determine overweight (BMI equal to 25.0-29.9), obesity (BMI greater 
than or equal to 30.0), and severe obesity (BMI greater than 40), because for most adults, it 
correlates with their amount of body fat. 
 Obese individuals are at increased risk for many diseases and health conditions, including 
the following: hypertension, osteoarthritis, dyslipidemia, type 2 diabetes, coronary heart 
disease, stroke, gallbladder disease, sleep apnea and respiratory problems, and endometrial, 
breast and colon cancers [1]. Obesity's strong association with hypertension is due to central 
and peripheral abnormalities that increase arterial pressure, such as activation of the 
sympathetic nervous system and the renin-angiotensin–aldosterone system. Obesity is also 
associated with endothelial dysfunction and changes in renal function that may contribute to 
hypertension [2]. Type 2 diabetes is associated with obesity, and stems from insulin 
resistance coupled with the inability to produce enough insulin to overcome this resistant 
state. Several adipocyte-derived factors have been shown to contribute to systemic insulin 
resistance, including resistin, TNFα, IL-6, and MCP-1. Also, adipocyte-derived free fatty 
acids contribute to insulin resistance in liver and muscle [3]. Obesity and its comorbidities 
increase the risk of coronary heart disease. When the arterial endothelium is exposed to high 
concentrations of non-esterified fatty acids or inflammatory cytokines derived from excess 
adipose tissue, vasoconstrictor hormones (in hypertension), and/or the products of 
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glycoxidation (in insulin resistance), these cells increase the expression of adhesion 
molecules [4]. Leukocyte adhesion and transmigration in the arterial intima initiate an 
inflammatory response, which is followed by lesion formation and atherosclerotic plaque 
formation [4]. Blood flow occlusion may result in a myocardial infarction or a stroke. The 
relationship of obesity to gallbladder disease remains to be elucidated, but may be due to 
obesity's association with insulin resistance. Insulin resistance causes a decrease in 
gallbladder contractility that may result in gallstone formation [5]. Obstructive sleep apnea is 
characterized by episodes of upper airway obstruction with a subsequent fall in blood oxygen 
saturation. Sleep apnea develops due to increased mechanical loads on the soft tissues of the 
upper airway and defects in compensatory neuromuscular responses [6]. Cancer risk is 
increased in obesity. In obese women, increased exposure to endogenous steroids may 
increase brease cancer risk. However, other factors may also be important. For example, 
increased serum insulin, insulin-like growth factor-I, and leptin may facilitate angiogenesis 
necessary for tumor growth [7]. Similarly, the increased risk of colon cancer in obesity may 
be the result of insulin resistance. Increased circulating levels of insulin, triglycerides, and 
non-esterified fatty acids are a proliferative stimulus for colonic epithelial cells and also 
expose them to reactive oxygen intermediates, which may promote colon cancer [8]. 
 The adverse health consequences of obesity have an immense economic impact. The 
World Bank estimated that in the late 1990s, obesity cost the U.S. 12% of its national health 
care budget, or $117 billion ($61 billion direct and $56 billion indirect health care costs). 
Moreover, the prevalence of overweight and obesity among children, adolescents and adults 
is rapidly increasing. Therefore, the future economic and health impacts of obesity are likely 
to be both substantial and long-lasting. 
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B. In vitro adipogenesis in the study of obesity 
 Obesity is the accumulation of excess adipose tissue (AT) mass. In obesity, adipocyte 
hyperplasia occurs through the recruitment and proliferation of preadipose cells in the 
vascular stroma of the adipose tissue [9-12]. This hyperplasia is mimicked in vitro by 
inducing fibroblastic preadipocytes to undergo mitotic clonal expansion, which culminates in 
the expression of genes required for specialization in triacylglycerol (TAG) storage and the 
mature adipocyte phenotype.  
 1. Overview of in vitro adipogenesis 
 Adipocyte development can be reproduced in cell culture. Much of what is known about 
adipocyte development has been elucidated from established cell lines that mimic adipocyte 
proliferation and differentiation in vivo. The 3T3-L1 preadipocyte cell line provides a well-
characterized model for the study of adipocyte-specific terminal differentiation. 3T3-L1 
preadipoctyes acquire the ability to differentiate after they reach confluence and become growth 
arrested in G0 of the cell cycle. The addition of 1-methyl-3-isobutylxanthine (MIX), 
dexamethasone (D), and high doses of insulin (I) or physiological doses of Insulin-like Growth 
Factor-1 to the serum-containing medium (MDI protocol) concurrently activates two different 
processes: the synchronous reentry of the preadipoctyes into the cell cycle and the initiation of 
differentiation. Therefore, one preadipocyte, which does not store large amounts of TAG, gives 
rise to 2-4 adipocytes that specialize in TAG storage [13].  
 2. Adipogenic transcription factors 
 The major transcriptional regulators that govern adipogenesis are peroxisome proliferator 
activated receptor gamma (PPARγ) and the CCAAT-enhancer binding protein (C/EBP) family 
members [14-17]. Several loss- and gain-of-function studies have shown that PPARγ is both 
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necessary and sufficient for in vitro adipogenesis [14, 18], as well as for in vivo adipogenesis [19, 
20]. Although PPAR-/- mice are not viable, adipose tissue-specific PPARγ-/- mice have much less 
adipose tissue than wild type mice [21]. The deletional strategies used to attain adipose tissue-
specific PPARγ-/- mice provide important information about the essential functions of PPARγ at 
different developmental stages. When PPARγ is deleted before adipose development, the mice are 
not viable. In contrast, when the deletional strategy is linked to aP2 gene expression, which does 
not peak until the adipocyte is mature, PPARγ is deleted at a later developmental stage [21]. The 
resulting adipose tissue-specific PPARγ-/- mice are viable, but have much less white adipose 
tissue. Similarly, C/EBPα-/- mice are not viable [22], and adipose tissue-specific C/EBPα-/- mice 
have much less fat than wild-type mice [23]. In vitro, C/EBPα is sufficient for the differentiation of 
3T3-L1 preadipoctyes, as inducible expression of C/EBPα in 3T3-L1 preadipocytes resulted in their 
differentiation without requiring the addition of the MDI induction cocktail [24].  
  Transcription factors in the C/EBP family function in a cascade-like manner to activate 
adipogenesis [25, 26]. C/EBPβ and C/EBPδ function synergistically to initiate the cascade 
[27]. In vitro, C/EBPβ/δ-deficient mouse embryonic fibroblasts fail to synthesize C/EBPα 
and PPARγ, and cannot differentiate into mature adipocytes with the aid of MDI [28]. 
However, ectopic expression of PPARγ2 and activation with its ligands induces their 
differentiation into adipocytes [29]. The resulting C/EBPβ/δ-/- adipocytes have less GLUT4 
and IRS-2 expression, and reduced insulin-responsive glucose uptake. In vivo, 
C/EBPβ·C/EBPδ double knockout mice have low viability, with survivors having 70% less 
AT than wild-type mice [28]. Therefore, while steps in the transcriptional cascade can be 
bypassed in vitro, C/EBPβ and C/EBPδ are important for in vivo adipocyte differentiation. 
 While C/EBPβ and C/EBPδ are synthesized and translocated to the nucleus within four 
hours after the induction of differentiation, they do not bind to DNA until eight hours later 
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[30]. The mechanism for this delay is unknown. C/EBPβ induces its own synthesis and 
cooperates with C/EBPδ to activate the synthesis of peroxisome proliferators-activated 
receptor gamma (PPARγ) and C/EBPα, which are critical adipogenic transcription factors 
[31]. C/EBPα is a differentiation-specific transcription factor with antiproliferative activity 
[32].C/EBPα is expressed between day 2 and day 5, and further induces the expression of 
PPARγ [33]. C/EBPα and PPARγ function synergistically to increase the expression of 
adipocytes-specific genes. By the fourth day after the induction of differentiation, the cells 
exhibit biochemical and morphological characteristics of mature adipocytes [34]. PPARγ 
transactivation of its target genes is required for adipocyte differentiation [35]. 
 
Figure 1.1: Progression of 3T3-L1 preadipocyte differentiation.  Major events of 
preadipocyte differentiation with periods of gene expression and stages of differentiation 
presented chronologically. C/EBP, CCAAT/enhancer binding protein; PPAR, peroxisome 
proliferator activated receptor; MIX, methylisobutylxanthine; DEX, dexamethasone. 
 
 
   
 
Modified from Ntambi JM and Kim Y-C, 2000, J Nutr 130(12): 3124S, [36]. 
 
 6
 3. The cell cycle 
 One round of the cell cycle produces 2 daughter cells. The cell cycle consists of four 
phases. Gap1 (G1) is the interval between mitosis and DNA replication that is characterized 
by cell growth. Late in G1 there is a transition, called the restriction point (R), when the cells 
are committed to complete the cell cycle even if mitogenic stimulation is withdrawn. 
Replication of DNA occurs during the synthesis (S) phase, which is followed by another gap 
phase (G2), during which growth and preparation for cell division occurs. Mitosis occurs in 
the M phase. Multiple regulatory mechanisms control the onset and completion of the cell-
cycle. The standard MDI protocol induces two-day postconfluent 3T3-L1 preadipocytes to 
undergo one to two rounds of mitotic clonal expansion. 
 The progression of the cell cycle is controlled by cyclins and cyclin-dependent protein 
kinases (cdks). Cdks lack kinase activity unless they are complexed to a cyclin molecule. The 
regulated synthesis and degradation of the cyclins leads to the cyclical ability of the cdks to 
phosphorylate target proteins, and thereby change their activation state. Cyclin/cdk 
complexes phosphorylate the Retinoblastoma protein (Rb).  
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Figure 1.2: Schematic diagram of the cell cycle. The major events of the cell cycle upon 
differentiation induction with MDI. Areas labeled within the circles represent stages of the 
cell cycle: G0, cell cycle arrest; G1, gap 1; S, synthesis; G2, gap 2; M, mitosis. Cdk, cyclin-
dependent kinase; MDI, 1-methyl-3-isobutylxanthine and dexamethasone and insulin; Rb, 
retinoblastoma protein.  
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 4. The Retinoblastoma protein 
 The Retinoblastoma protein (Rb) is a nuclear phosphoprotein that restricts the 
progression of the cell cycle, and in some tissues, promotes differentiation [37-39]. 
Progression of the cell cycle from the G1 to the S phase is regulated by the sequential 
phosphorylation of Rb by cyclin-dependent kinases. In G1, the hypophosphorylated form of 
Rb binds and sequesters members of the E2F family of transcription factors that are required 
for the expression of genes necessary for DNA synthesis [40-42]. Phosphorylation of Rb late 
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in G1 causes these transcription factors to be released, permitting cell cycle progression. In 
addition to interacting with transcription factors, Rb can interact directly with elements of the 
transcriptional machinery [43]. Almost all of these proteins interact with the 
hypophosphorylated form of Rb and not with the hyperphosphorylated form of Rb. Thus, 
Rb’s regulatory function in cell cycle progression plays a key role in cell proliferation. In 
addition to its role in proliferation, Rb is critical in differentiation. Rb binds to transcription 
factors involved in differentiation [39, 44, 45], including members of the CCAAT/enhancer 
binding protein (C/EBP) family of transcription factors [37, 38, 46]. A direct interaction 
between Rb and the C/EBPβ isoform was detected in U937 cells induced to differentiate into 
monocytes and macrophages [37, 46]. Rb appears to increase or decrease the DNA-binding 
activity of C/EBPβ depending on the promoter being investigated. For example, Rb 
transfection increased the C/EBPβ-activation of an SP-D promoter-reporter [38]. In contrast 
Rb transfection decreased C/EBPβ-activation of the C/EBPα promoter-reporter gene [47]. 
C. Obesity, infection, and immune dysfunction  
 1. Obesity and infection 
  a. Obesity and infection in humans  
 Obesity increases susceptibility to infections. Data on the incidence and outcome of 
specific infections in obese people are limited. The available data suggest that obese people 
are more likely than people of normal weight to develop postoperative infections and 
nosocomial infections, as well to develop community-acquired infections [48].  
 Among surgical patients, obesity increases the risk of nosocomial infections such as 
wound infections, and bacteraemia [49]. For example, obese women undergoing elective 
hysterectomy for fibromas have an increased risk of surgical site infection, particularly if no 
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antimicrobial prophylaxis has been administered [50].  Morbid obesity is an independent risk 
factor for surgical site infection after spinal surgery [51, 52]. Obesity increases the incidence 
of midiastinitis as well as of deep and superficial sternal infection after surgery for coronary 
artery bypass graft [53-55]. 
 In the hospital, obese patients are more likely to develop infections. For example, obese 
women are nearly two times more likely to develop postpartum urinary tract infections [56]. 
In a matched cohort study of 170 mechanically ventilated obese patients with 170 normal 
weight patients, the obese patients had two-fold higher mortality. This higher mortality was 
explained by higher incidence of infectious complications including sepsis, ventilator-
associated pneumonia, and central venous catheter-related infections [56]. In a matched 
cohort of 15 obese burn patients with 15 normal weight burn patients, the obese patients had 
higher incidence of bacteremia and sepsis [57]. 
 Obesity increases the risk of community-acquired infections. In a large population study 
of 26429 men aged 44-79 years from the Health Professionals Follow-up Study and 78062 
women aged 27-44 years from the Nurses Health Study II, overweight and obesity were 
associated with increased risk of community-acquired pneumonia [58]. In a Polish cross-
sectional field study of 1129 9-year old school children, overweight and obese children had 
twice the risk of acute respiratory infection than normal weight children [59]. Therefore, in 
humans, obesity increases the risk of infection. 
  b. Diet-induced obesity and infection in animals  
 Reports of the incidence of community-acquired infection among diet-induced obese 
animals are lacking. However, there is evidence that mice with diet-induced obesity have 
impaired resistance to experimentally-induced bacterial infection, parasitic infection, and 
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viral infection. Relative to their lean counterparts, diet-induced obese mice that were 
experimentally infected with Klebsiella pneumoniae or Salmonella typhimurium had 
increased morbidity [60]. Additionally, diet-induced obese mice have greater liver pathology 
due to Schistosomiasis mansoni relative to lean mice [61].  Diet-induced obese mice infected 
with influenza A/PR/8/34 had higher lung pathology and 6-fold higher mortality relative to 
lean mice [62].   
  c. Genetic obesity in humans, ob/ob and db/db animals and infection 
 Obese humans with leptin and leptin-receptor gene mutations are at increased risk for 
infections, including urinary tract infections [63] and upper respiratory tract infections [64]. 
However, data on the increased risk of infection from specific pathogens is unknown.  
 Genetically obese ob/ob mice are highly susceptible to bacterial infections. Ob/ob mice 
intranasally infected with Mycobacterium tuberculosis [65], Streptococcus pneumoniae [66], 
or Klebsiella pneumonae [67, 68] have increased bacterial load and decreased survival post- 
infection relative to mice with normal serum leptin levels. Similarly, ob/ob and db/db mice 
intravenously infected with Listeria monocytogenes have increased bacterial growth in their 
livers and increased mortality relative to heterozygous littermates [69]. 
 2. Obesity and immune dysfunction 
  a. Obesity and immune dysfunction in humans 
 Obesity is associated with immune dysfunction [62, 70, 71]. Relative to lean individuals, 
obese individuals have higher risk of infections [49], require longer hospitalizations and 
longer periods of antibiotic treatment [72]. The cellular and molecular mechanisms 
responsible for the immune dysfunction are largely unknown. Some mechanisms of the 
immune dysfunction are impaired cell-mediated immune responses [73], lower 
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lymphoproliferative response to mitogen stimulation [74], and decreased antibody response 
to vaccines, such as hepatitis and tetanus vaccines [75-80]. However, not all studies support 
the hypothesis that obesity negatively affects the immune response [70, 81]. Many of the 
reasons that may explain the conflicting findings can be broadly categorized as subject 
heterogeneity, such as the degree of adiposity, age, gender, and co-morbidities. Another 
explanation for discrepant conclusions is that different parameters of the immune system 
were studied. 
  b. Obesity and immune dysfunction in animals 
 Results from studies in rodents support the results from human studies demonstrating 
impairment of the innate and adaptive immune responses in diet-induced obesity (DIO).  The 
following are impaired or reduced in DIO mice and rats relative to their lean counterparts: 
macrophage phagocytic activity [82]; contact hypersensitivity [83]; natural killer cell 
cytotoxicity [62, 84]; lymphoproliferative response to mitogens [84], with altered splenocyte 
cytokine production [85]. 
 Although DIO mice most closely mimic human obesity, genetic mouse models of obesity 
such as ob/ob and db/db mice are widely studied. The ob/ob mice lack functional leptin, 
while db/db mice lack a functional leptin receptor. Because leptin receptors are found in all 
cells of the innate and adaptive immune response [86, 87], leptin can affect many aspects of 
the immune system [88]. The following are impaired or reduced in ob/ob mice relative to 
wild type mice: macrophage phagocytotic activity [89-91]; T lymphocyte number and 
thymus and spleen weights [92-94]; Dendritic cell antigen presentation [95]. 
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 3. Obesity and inflammation 
 Obesity is associated with a state of chronic, low-grade inflammation. The classic 
symptoms of inflammation (redness, warmth, swelling, and pain) are absent in obesity. 
Instead, other features of inflammation are present. For example, compared to normal weight 
individuals, obese individuals have higher serum concentrations of inflammatory mediators, 
such as C-reactive protein [96], serum amyloid A [97], MCP-1 and IL-8 [98], TNFα and IL-6 
[99-101]. In addition, obesity increases the numbers and activation state of macrophages in 
adipose tissue [102]. 
  a. Obesity and inflammation in the liver 
 Obesity is associated with nonalcoholic fatty liver disease (NAFLD), which may or may 
not include inflammatory changes. Although the prevalence of NAFLD in the normal weight 
adult population is 10-15% [103, 104], in obese adults the prevalence of NAFLD increases to 
74%; in morbidly obese adults, the prevalence of NAFLD increases to 90% [105, 106]. 
NAFLD comprises a spectrum of disorders ranging from simple fatty liver (steatosis), to 
nonalcoholic steatohepatitis (NASH) [104, 107]. In the liver, inflammation is typically 
defined by histopathological parameters. However, a liver biopsy is required for diagnostic 
purposes. Because biopsies are invasive and have the potential for adverse consequences 
such as infection and internal bleeding, alternative screening techniques have been 
investigated. Ultrasound, computerized tomography, and magnetic resonance imaging can 
detect NAFLD, but they do not distinguish between simple liver steatosis and more advanced 
forms of liver disease, such as NASH [108]. Elevated levels of serum aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) are indicators of hepatocyte 
damage but are not well correlated with the changes in the degree of liver steatosis or fibrosis 
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[109, 110]. Indeed, Garcia-Monzon et al. reported that 54% of adults with severe NASH had 
normal AST and ALT levels [111]. Central adiposity, serum TAG, insulin, C-peptide, and 
leptin concentrations have also been used to estimate the presence of NAFLD [112]. 
 Hepatocyte TAG accumulation in excess of 5% of the total mass is considered liver 
steatosis. TAG accumulation occurs when there is increased free fatty acid flux to the liver, 
such as during excess food consumption. The ‘two-hit’ theory of NAFLD by James and Day 
[113] proposes that liver TAG accumulation (the first hit) makes the liver more susceptible to 
damage from a second hit [114]. The second hit may result from increased free fatty acid 
(FFA) delivery to the liver and/or increased TNFα concentrations [114]. In obesity, much of 
the FFAs come from adipose tissue, which will be discussed in a later section. The liver 
becomes increasingly insulin resistant due to FFA activation of hepatic PKC-δ [115], which 
inhibits IRS-1/2 tyrosine phosphorylation. In addition, the FFAs activate IKK-β. IKK-β 
phosphorylation of IκB-α causes IκB-α to dissociate from NF-κB. NF-κB is a transcriptional 
activator for inflammatory cytokines such as TNFα, IL-1β, IL-6, and MCP-1 [115]. The 
increase in TNFα expression not only exacerbates insulin resistance by impairing the insulin 
signaling pathway, TNFα impairs the flow of electrons in the electron transport chain, 
resulting in the generation of reactive oxygen species (ROS) [114]. In the liver, the increased 
ROS (the second hit) in the presence of steatosis (the first hit) results in lipid peroxidation, 
further ROS production, TNFα expression, insulin resistance and subsequent NASH [114]. 
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Figure 1.3: The role of TNFα and free fatty acids in the pathogenesis of NASH. Visceral 
obesity increases serum FFA and TNFα concentrations. FFA release in adipocytes is 
exacerbated by TNFα-induced insulin resistance mediated by IKKβ activation. FFA, free 
fatty acids; IKKβ, inhibitor kappa kinase beta; NASH, non-alcoholic steatohepatitis; PPARα, 
peroxisome proliferator-activated receptor α; UCP-2, uncoupling protein-2. 
 
From Day CP, 2002, Best Practice & Research Clinical Gastroenterology,16(5):668, [114].  
 
 
   i. Cellular infiltrate  
 Park et al. reported that among individuals with NAFLD, those whose disease had 
progressed to NASH had more CD68+ Kupffer cells than those who had liver steatosis [110]. 
Obese individuals with NAFLD have increased liver infiltration of CD8+ T lymphocytes and 
CD11c+ macrophages [111]. Although the authors of these studies refer to the CD68+ cells 
as Kupffer cells, and CD11c+ cells as macrophages, respectively, this distinction is not 
entirely clear. CD68 is a scavenger receptor that is expressed not only on Kupffer cells, but 
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also on monocytes/macrophages, neutrophils, and dendritic cells (DC) [116]. Similarly, 
CD11c is expressed not only on macrophages, but is also expressed on monocytes, 
neutrophils, natural killer (NK) cells, and DC [116]. Therefore, in NAFLD the precise 
identification of the infiltrating cells is unknown, but the infiltrate consists predominantly of 
cells associated with inflammation and the innate immune system.   
   ii. Inflammatory mediators 
 The cellular infiltrate associated with NAFLD is a potential source of inflammatory 
mediators, as are the resident Kupffer cells and hepatocytes themselves. Inflammatory 
cytokines and chemokines have recently been studied in association with NAFLD. In 
humans, NAFLD is associated with elevated serum levels of IL-6 and MCP-1 [117]. Crespo 
et al. found that obese patients with NASH compared to those without it have increased liver 
expression of TNFα [118].  A liver biopsy to measure cytokine and chemokine mRNA poses 
some health risks. Therefore, liver gene expression has been measured mainly in people at 
risk of liver disease which makes the study’s findings less generalizable to the population at 
large. Mice have been used to study liver steatosis and cytokine expression. C57BL/6 mice 
fed a high fat (HF) diet developed liver steatosis after 10 weeks [119]. Cytokines expressed 
by the liver may be detected in the serum. Although serum TNFα, and IL-6 levels were not 
increased, serum MCP-1 levels were increased in DIO mice [120, 121]. In contrast to the 
serum cytokines, liver mRNAs encoding IL-6, IL-1β and TNF-α were increased several fold 
in DIO mice relative to chow-fed controls [122]. 
  b. Obesity and inflammation in the adipose tissue 
 In the obese state, visceral adipose tissue (AT) has increased numbers of macrophages 
and T lymphocytes and increased concentrations of inflammatory mediators. 
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   i. Regional differences in adipose tissue inflammation 
 Adipose tissues have important regional differences. In addition to metabolic differences 
[123], AT depots differ in the degree of cellular infiltration during obesity. In DIO and db/db 
mice [124, 125], and severely obese humans [126], visceral AT contatins a higher number of 
macrophages than subcutaneous AT. Differences in local production of chemokines may 
account for this discrepancy. For example, the expression of IL-8 and MCP-1 is greater in 
visceral AT than subcutaneous AT [127, 128]. The depot-specific difference in protein 
expression extends beyond chemokines to include hormones and cytokines. In humans, 
relative to visceral AT, subcutaneous AT expresses more adiponectin mRNA [129] and 
leptin mRNA [130], and releases more leptin protein [131]. In contrast, the expression of IL-
6 occurs predominantly in the visceral depots [132]. While these regional differences may be 
of physiological and clinical importance, there has not been a systematic study of depot-
specific changes in macrophage infiltration or cytokine gene expression during the onset of 
obesity. 
   ii. Cellular infiltrate  
 Recently, inflammatory lesions have been identified in the AT of obese animals and 
humans [133, 134]. Macrophages are the predominant infiltrate [124, 135]; however, a small 
proportion of T cells [136] and neutrophils may also be present [133]. In obese children, but 
not in lean children, microgranulomas were found in the AT. Some microgranulomas 
contained macrophages with necrotic adipocytes surrounded by fibrosis [133], indicative of 
chronic inflammation in the AT during early stages of obesity. Subsequent weight loss results 
in decreased macrophage infiltration of the AT [137]. In DIO mice, macrophages have been 
found to aggregate around non-viable adipocytes, apparently scavenging adipocyte fragments 
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and residual lipid droplets [134]. However, it is not known to what degree the infiltrating 
cells ameliorate or exacerbate the inflammation in the AT. 
   iii. Inflammatory mediators 
 In human obesity, serum concentrations of the inflammatory cytokines and chemokines 
IL-6, TNFα, and MCP-1 are elevated [99-101]. These cytokines and chemokines are 
expressed in AT [138] and may originate from either adipocytes [139] or from cells in the 
stromal vascular fraction, such as macrophages [124]. Significant amounts of plasma IL-6 
originate from AT, especially from the visceral AT depots [140, 141]. In contrast, while 
TNFα gene expression in AT increases in obesity, it likely acts in an autocrine fashion, 
because it does not contribute significantly to circulating concentrations of TNFα [139] 
[142].  It is hypothesized that the increase in cytokine expression results from the increased 
FFA concentrations. The FFAs activate IKK-β. IKK-β phosphorylation of IκB-α causes IκB-
α to dissociate from NF-κB. NF-κB is a transcriptional activator for inflammatory cytokines 
such as IL-6, TNFα, IL-1β,  and MCP-1 [115]. 
D. Influenza A virus  
 Viruses are infectious agents that are obligate intracellular parasites. They infect and use 
host cellular factors for their replication.   
 1. Public health impact of influenza virus infection 
 Influenza virus infection is a major cause of morbidity and mortality worldwide. 
Symptoms of influenza infection include headache, cough, sore throat, nasal congestion, 
sneezing, body aches, and fever. During a pandemic, 20-40% of the world’s population may 
be infected [143]. In an average year, influenza virus infects approximately 10-20% of the 
U.S. population. Annually in the U.S., influenza viruses infect about 50 million people, are 
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responsible for approximately 36,000 deaths and 114,000 hospitalizations [143]. In the late 
1990’s it was estimated that the direct medical cost of influenza infection was $1-3 billion; 
indirect costs ranged from $10-15 billion [144]. Given the health care costs and high 
infection rates, influenza is a significant socioeconomic burden [144]. 
 2. Overview of influenza A virus 
 Influenza viruses belong to the Orthomyxoviridae family of viruses, which have a 
negative-sense, single-stranded, segmented RNA genome [145]. There are 5 different genera 
in the family due to antigenic differences between their nucleocapsid and matrix proteins. 
Influenza A viruses are further divided based on the antigenic differences of their 
hemagglutinin (HA) and neuraminidase (NA) glycoproteins. 
 The influenza A virus has a lipid envelope that is derived from the plasma membrane of 
the host cell. This envelope contains the HA and NA proteins that form projections on the 
surface of the virus. Inside the envelope the ribonucleoprotein (RNP) complex consists of 8 
RNA segments in association with nucleoproteins, and the RNA-polymerase proteins. 
 3. Mechanism of influenza A virus infection 
 To start the process of infection, the influenza virus attaches via HA proteins to sialic 
acid residues of glycoproteins on the host cell surface. The HA of human influenza viruses 
preferentially bind to sialic acid attached to galactose by an α2,6 linkage. This limits host 
range because avian influenza viruses predominantly bind to an α2,3 linkage. However, this 
specificity is not absolute because humans and birds contain both linkages [145]. Also, 
viruses can adapt to a host. In addition, influenza viruses can adapt to infect mice, which are 
not naturally infected with the virus, by the natural selection of mutations in the receptor-
binding site of the viral HA. 
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 After attachment, the viruses enter cells by receptor-mediated endocytosis. In the low pH 
of the endosome, the HA undergoes a conformational change which enables it to fuse with 
the endosome membrane and open a pore that releases the viral RNP complex into the cell. 
Subsequently, the cell’s nuclear import machinery traffics the viral RNA and nucleoproteins 
to the nucleus for viral RNA synthesis. Influenza virus mRNA synthesis is dependent on 
cellular RNA polymerase II activity. This is because it requires a 5′ capped primer, which it 
cleaves from host mRNA to initiate viral mRNA synthesis [145]. RNA viruses must encode 
an RNA polymerase since cells do not normally replicate RNA. In the case of all RNA 
viruses, virus-encoded proteins are required to form a replicase complex to replicate the viral 
RNA since cells do not possess RNA to RNA copying enzymes. In the case of the minus-
strand RNA viruses, these RNA synthesizing enzymes also synthesize mRNA and are 
packaged in the virion, because their genomes cannot function as messengers. Viral 
replication occurs in 2 steps. First, a full-length positive-sense copy of the vRNA is 
transcribed (cRNA). Next, it is used as a template to produce more vRNA. 
 Influenza viruses assemble and form buds at the plasma membrane on the apical surface 
of the cell. This is important in the pathogenesis of influenza because the infection is 
generally restricted to the cells lining the respiratory tract. After the membranes fuse at the 
base of the bud, the enveloped virus particle is released. Influenza viruses must be cleaved 
from the cell membrane because their HA binds to the host cell’s sialic acid receptors. The 
viral NA enzyme removes the sialic acid, releasing the virus and allowing the virus to spread. 
Influenza viruses do not cause persistent or latent infections. They survive in the population 
by being transmitted from one host to another, typically in aerosolized droplets during 
coughing or sneezing. 
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Figure 1.4: Illustration of the influenza virus replication cycle. 
Illustration from Knipe DM, and Howley PM, Fields Virology 5th ed., Chapter 47 [145]. 
 
E. Immune response to influenza A virus infection 
 The influenza virus targets airway epithelial cells; however, it can also infect monocytes 
and alveolar macrophages [146]. Although the influenza virus infection is typically limited to 
the respiratory mucosa, it not only causes respiratory symptoms such as nasal discharge, sore 
throat and cough, but also causes systemic symptoms such as chills, myalgia, anorexia, 
headache, sleepiness and fever (reviewed in [147]). These symptoms are caused by 
inflammatory mediators that are released at the site of infection and initiate a cascade of 
events necessary for the elimination of the virus and tissue repair. For example, fever is 
generally beneficial to host defense because most pathogens grow better at lower 
temperatures and adaptive immune responses are moe intense at elevated temperatures [148]. 
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The initial release of inflammatory mediators by infected lung epithelial cells and alveolar 
macrophages results in the extravasation of neutrophils, macrophages and then T cells from 
the blood into the infected lung tissue [149]. Therefore, the immune response to influenza 
virus infection includes both innate and adaptive immune processes, which function 
interdependently. 
 1. Innate immune response to influenza A virus infection 
 The influenza A virus primarily targets epithelial cells of the respiratory tract. These cells 
produce large numbers of virion, which can then infect the resident alveolar macrophages 
[146]. Virus infection activates members of the toll-like receptor (TLR) family, which 
subsequently activates the transcription factors involved in chemokine and cytokine gene 
expression. These include nuclear factor kappa B (NF-κB), interferon regulatory factors, and 
signal transducers and activators of transcription (STATs) [150]. Cytokines and chemokines 
are reviewed later in the introduction. The increased expression of inflammatory chemokines 
and cytokines causes a rapid infiltration of neutrophils [151], which is followed by 
infiltration of other inflammatory cells such as macrophages and natural killer (NK) cells. 
Because viruses are intracellular pathogens, cell-mediated mechanisms are responsible for 
their elimination. As will be discussed in the section on adaptive immunity, cytotoxic T (Tc) 
lymphocytes are mainly responsible for the clearance of influenza virus infections; however, 
there is a 4-6 day lag before there are sufficient numbers of antigen-specific Tc cells to 
successfully eliminate the infected cells [116]. During this delay, neutrophils, macrophages, 
and NK cells help to control viral spread. Neutrophils and macrophages phagocytose 
influenza virus-infected cells [152, 153], while NK cells lyse virally-infected cells. 
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 2. Adaptive immune response to influenza A virus infection  
 During the adaptive immune response, naïve antigen-specific B and T cells are activated 
to undergo clonal expansion and development of memory cells that can prevent reinfection 
with an antigenically similar pathogen [116]. An adaptive immune response is necessary to 
recover from influenza infection, because CD4-/- and CD8-/- animals die from influenza 
infection [154]. 
  a. Humoral immune response  
 Humoral immunity refers to antibody-mediated protection. B-cells, with help from T 
cells, produce antibodies. In influenza A virus infection, B-cell activation is mediated by T-
cells and activating cytokines. Typically, virions are phagocytosed by antigen presenting 
cells (APC) such as DC or macrophages. The APC then processes the protein portions of the 
virion into peptide fragments and re-expresses these peptides on the surface of the APC in 
association with MHC-II molecules [155]. The complex of the antigen/MHC-II molecule can 
be recognized by the T-cell receptor (TCR) on the surface of the T-helper (Th) cells. Then, 
the CD4+ coreceptor binds to the MHC-II molecule. This induces the expression of the 
CD40 ligand (CD40L) on the Th cell. B-cell binding to the CD40L induces their expression 
of cytokine receptors. The activated Th cells secrete cytokines such as IL-4 that induce the B-
cells to proliferate and terminally differentiate into antibody forming plasma cells [155]. 
Because antigen-specific B-cells are rare, it takes several days for sufficient proliferation of 
B cells to occur. 
 While humoral immunity does little to contain the primary influenza virus infection, it is 
important for resistance to subsequent influenza infections by virions that are antigenically 
similar. During a second exposure, the infection can be blocked by antibodies that are 
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secreted into the mucous. Antibodies directed against peptides from viral HA and NA 
proteins are especially important. Antibodies to epitopes of the virus’ HA protein prevent the 
virus from binding to the sialic acid residues on the host cell’s receptors, whereas the NA 
antibodies prevent the virus from being released by the infected cell [145]. Antibodies that 
bind to viruses engage Fc receptors on phagocytes, facilitating phagosomal destruction [116]. 
Similarly, antibodies that bind to viral peptides displayed on the surfaces of infected host 
cells can engage the Fc receptors of NK cells, neutrophils and macrophages, inducing 
antibody-dependent cell-mediated cytotoxicity [116]. 
  b. Cell-mediated immune response  
 Cytotoxic T (Tc) lymphocyes are the main effector cells for cell-mediated immune 
responses. Tc lymphocytes are also designated CD8+ T-cells, because the CD8 molecule is 
part of the coreceptor that recognizes the MHC-I proteins (in contrast to CD4+ T-cells that 
recognize MHC-II). 
 During influenza infection, viruses are taken up by APCs via receptor-mediated 
endocytosis or phagocytosis. The APCs, especially dendritic cells, migrate from the site of 
infection to efferent lymph nodes where they present viral peptides for recognition by 
antigen-specific T cells. The intracellular nature of viral replication means that viral antigens 
are processed by the host cell’s endogenous antigen-processing pathway and viral peptides 
are displayed on MHC-I molecules [116]. Tc lymphocytes kill virus-infected cells by 
secreting perforin or by inducing Fas-mediated apoptosis which activates caspases [116]. Tc 
lymphocytes rapidly kill an inflected host cell, which prevents the virus from spreading. 
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 3. Cytokines and chemokines function in innate and adaptive immunity 
 Cytokines are necessary for both the initiation and control of innate and adaptive immune 
responses. Cytokines act as intercellular messengers among cells, especially among 
leukocytes, yet because of their small size, low effective concentration, and variable half-life, 
cytokine activities are difficult to evaluate in vivo. Most studies have shown that cytokine 
signaling is predominantly autocrine and paracrine; however, cytokine signaling may also 
induce a systemic response. Chemokines are cytokines that function as chemoattractants for 
leukocytes. By binding to their receptors on cell surfaces, cytokines trigger intracellular 
signaling pathways that induce gene expression which results in activation, proliferation, 
survival, apoptosis, migration, and differentiation [116]. Furthermore, many cytokines have 
functional redundancy because receptors from different families can share component 
intercellular chains [156]. 
 Because the cytokine network is so complex, it is useful to group cytokines into 
categories based on their immune function [157]. 
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Table 1.1: Cytokines and chemokines that participate in inflammation and systemic 
responses to infection.  
 
 
Cytokines participating in 
inflammation and systemic  
responses to infection 
 
 
Response 
TNFα              Inflammation  
 
 
 
 
 
                              
                   Extracellular pathogen 
                   Intracellular pathogen 
↑ APP by hepatocytes 
↑ macrophage production of IL-1, IL-6, TNFα 
↑ neutrophil production of IL-1, IL-6, IL-8 
↑ neutrophil, macrophage microbicidal killing 
↑ activation, adhesion, and extravasation of 
neutrophils, macrophages, Tc lymphocytes 
↑ MHC-II on APC 
↑ MHC-I on target cells 
↑ B cell proliferation, antibody production 
↑ T cell production of IFN 
IL-1β          Inflammation 
 
 
 
↑ APP by hepatocytes 
↑ adhesion molecules on endothelial cells & 
leukocytes 
↑ IL-6, TNFα, MIP-1α production 
IL-6            Inflammation 
 
                  Extracellular pathogen 
↑ APP by hepatocytes 
↑ neutrophil microbicidal functions 
↑ B cell terminal differentiation 
 
Chemokines favoring inflammation 
 
Response 
 
MCP-1/CCL2 (CCR2, CCR4 receptors) Chemoattractant for monocytes, activated T 
cells, Th2, basophils, NK cells. Not neutrophils
MIP-1α/CCL3    (CCR1, CCR4, CCR5) Chemoattractant for monocytes, macrophages, 
Tc, Th1, DC, NK cells, basophils  
Modified from Mak TW, and Saunders ME, 2006, The Immune Response, Elsevier 
Academic Press, p511-513 [116]. 
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 4. Influenza virus infection may alter adipose tissue inflammation. 
 As previously discussed, the influenza virus infection is typically localized to the 
respiratory mucosa. Cytokines produced at the site of infection are responsible for initiation 
of the local inflammatory response, as well as some systemic effects [158].  TNFα, IL-1β, 
and IL-6, acting alone or in combination, have been demonstrated to affect various tissues 
and organs indirectly and directly. For example, there is evidence that cytokines cross the 
blood brain barrier to act on the hypothalamus [159], although they may also communicate 
with the CNS via their actions on the vagus nerve [160]. The hypothalamic-pituitary-adrenal 
(HPA) axis plays a critical role in the immune response [161] by regulating cortisol and 
catecholamines. Therefore, acting through the hypothalamus, cytokines indirectly affect the 
release of cortisol and catecholamines by the adrenal gland. In addition, cytokines can 
directly affect the acute phase response by the liver [162], and insulin secretion by the 
pancreas [163]. Changes in the concentrations of hormones, neuropeptides, cytokines, and 
other proteins can alter AT gene expression. Figure 1.5 illustrates how an influenza virus 
infection may alter AT gene expression. 
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Figure 1.5: Influenza A virus infection induces systemic changes that may alter adipose 
tissue gene expression. Influenza virus infection of respiratory mucosal cells induces 
expression of inflammatory cytokines which have local and systemic effects. Cytokines can 
act directly or indirectly on various tissues and organs to alter hormone, neuropeptide, and 
protein concentrations, including their own, which may alter AT expression of cytokines. 
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 In obesity, inflammatory cytokines originating from the adipose tissue may contribute to 
an adverse outcome during infection. Increased serum concentrations of IL-6, as seen in 
obese humans, have been associated with a higher mortality from pneumonia [164]. 
Increased mRNA transcripts for TNFα and IL-1β, which have been detected in AT of obese 
animals [165-167], may also alter the outcome of infection. Increased serum concentrations 
of TNFα exacerbate the inflammatory infiltrate in the lungs during influenza A viral 
pneumonia [168]. In contrast, IL-1β appears to be important in clearing the virus [169]. 
 5. Effect of dietary lipids on the immune response 
 The effect of diet on the immune response has gained much attention. Recently, there has 
been interest in how specific lipids may modulate the immune response. One link between 
fatty acids, inflammation and immunity are eicosanoids. Eicosanoids, a collective term for 
C20 polyunsaturated fatty acids (PUFA), mediate inflammation and immune responses [170]. 
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The most prevalent dietary precursor for eicosanoids is linoleic acid [170]. Through a series 
of elongation and desaturation steps, linoleic acid is converted to arachidonic acid (ARA; 
20:4n-6). However, linolenic acid and other n-3 fatty acids (found in oily fish, soybean and 
canola oils) are also substrates for eicosanoid synthesis. After elongation and desaturation, 
linolenic acid is converted to eicosapentanoic acid (EPA; 20:5n-3). ARA and EPA are 
incorporated into the sn-2 position of phospholipids in the plasma membrane. Phospholipase 
A2 activation releases the ARA or EPA from the phospholipid. The ARA and EPA are 
substrates for both cyclooxygenase and lipoxygenase enzymes. When EPA is used as the 
substrate instead of ARA, class-3 , rather than class-2 prostaglandins, thromboxanes and 
leukotrienes  are synthesized. These class-3 molecules derived from EPA have a slightly 
different structure, and are less potent inflammatory mediators than those formed from ARA 
[170].  Thus, diets high in n-3 fatty acids, including EPA and DHA may decrease 
inflammation. 
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Figure 1.6: Synthesis of long-chain n-6 and n-3 PUFAs from their precursors.  
 
 Figure from Wanten GJ, et al., 2007, Am J Clin Nutr  85:1171-1184 [171]. 
  
 PUFAs are the most studied type of dietary lipid in immune function. Because obese 
individuals have increased serum concentrations of TNFα and IL-6 [172], two studies in 
obese men investigated the effects of supplementation with fish oil, which is rich in EPA and 
docosahexanoic acid (DHA; 22:6n-3), on serum TNFα and IL-6 concentrations. Jellema et al. 
provided 1g EPA and 1g DHA, while Chan et al. provided 3g EPA and 4g DHA [173, 174]. 
Compliance was ascertained compliance by counting the remaining capsules at the end of the 
study. Fish oil supplementation increased plasma EPA and DHA concentrations but did not 
affect the plasma TNFα or IL-6 concentrations in either study. This suggests that long chain 
n-3 PUFA do not reduce the low-grade inflammatory state in obesity [170]. 
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  There have been many studies on the effects of long-chain n-3 PUFA supplementation on 
markers of immune function. A review by Sijben et al. concluded that overall, in healthy 
adults, ex vivo T-cell proliferation and cytokine production induced by Con A was not 
reduced, and monocyte production of TNFα, IL-1β and IL-6 in response to LPS was not 
reduced [170]. Therefore, although there are numerous studies on the effect of long-chain n-3 
PUFA, it appears that factors such as genetic variation, health status or disease, type of 
immune stimulation, and age, confound the effect of long-chain n-3 PUFA on the immune 
system. Studies conducted in animals that investigated the influence of dietary n-3 fatty acids 
on host survival and/or pathogen clearance are inconclusive, some showing that n-3 PUFAs 
improve host defense and others showing impairment [175]. 
 While studies on dietary long chain n-3 PUFAs have not demonstrated consistent effects 
on markers of inflammation or immune function, studies of dietary saturated fatty acids 
(SFAs) have been even less informative. Consumption of diets high in SFA has been 
associated with increased risk of cardiovascular disease. Therefore it has been postulated that 
SFA may alter the inflammatory responses. However, there is little experimental research to 
support the epidemiological evidence. For example, in a double-blind cross-over study 
design in hypercholesterolemic adults, 30% of calories were provided from butter, stick 
margarine, or soybean oil [176]. Relative to the other diets, the butter diet had twice the 
amount of SFA, the stick margarine diet had four-fold more trans-fatty acids, and the 
soybean oil diet had four-fold more PUFA. Among the groups, there were no differences in 
conA-stimulated PGE2 or IL-2 production by PBMCs, delayed type hypersensitivity 
response, or in lymphocyte proliferative response [176]. Hence, consumption of diets with 
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varying degrees and types of fat saturation did not adversely affect these indices of cellular 
immunity. 
 Waitzberg et al. reviewed the effect of lipids administered parenterally [177]. While 
several studies reported that certain lipid emulsions altered monocyte/macrophage and 
neutrophil phagocytosis, other studies of the same lipid emulsions reported no effect. In mice 
fed either a LF diet or HF diet with 20% hydrogenated coconut oil (w/w), there was no 
difference in peritoneal macrophage superoxide, hydrogen peroxide, or nitric oxide 
production, PGE2, TXB2, or LTB4, TNFα, IL-1β or IL-6 production [178]. In lymphocytes, 
there was no difference in proliferation or in the production of IL-2, IL-4, IL-10, IFNγ [179].  
 The high-fat diets consumed by mice in our studies reflected diets could reasonably be 
consumed by humans. Described as percent kilocalories protein:carbohydrate:fat, the high-fat 
mouse diet was 20:35:45. The typical American diet is 16:50:34 [180]. Therefore, the 
increased fat content, considering kilocalories, trans fatty acids and saturated fat, and n-3:n-6 
PUFAs, is roughly equivalent to what a typical American could consume by consuming one 
"super-size" fast food meal per day. 
 F. Questions raised by the literature 
 It has long been recognized that malnutrition is associated with immune impairment. 
However, only recently have the effects of obesity on the immune response received 
attention. Evidence indicates that obesity results in a low-grade, chronic inflammatory state. 
This raises the question about the role that adipose tissue itself plays during infection. Studies 
suggest that adipose tissue depots differ with respect to their inflammatory state, yet this 
information is incomplete due to the lack of research on the retroperitoneal depot. 
Furthermore, many studies on inflammation in adipose tissue were conducted after the onset 
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of insulin resistance, thereby confounding whether the inflammation is due to obesity or the 
insulin resistance. Chapter III provides new data on the development of inflammation in a 
time-dependent and tissue-specific manner. 
 Although adipose tissue in obese humans and mice produces pro-inflammatory mediators 
and accumulates macrophages, there are no studies demonstrating how this inflammation 
may affect the response to an infectious disease. Previous work in our laboratory 
demonstrated that obese mice have a worse outcome than lean mice after an influenza 
infection. In Chapter IV, the effect of influenza infection on adipose tissue and liver 
inflammation are reported.  
 Taken together, our studies demonstrate that obesity can have a profound influence on the 
immune response to an infectious disease and that the adipose tissue itself may be a major 
component of the dysregulated immune response during influenza infection.  
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A. Abstract 
 Two pathways are initiated upon 3T3-L1 preadipocyte differentiation: the reentry of cells 
into the cell cycle and the initiation of a cascade of transcriptional events that “prime” the 
cell for differentiation. The “priming” event involves the synthesis of members of the 
CCAAT/enhancer binding protein (C/EBP) family of transcription factors. However, the 
relationship between these two pathways is unknown. Here we report that in the 3T3-L1 
preadipocytes induced to differentiate, cell cycle progression and the initiation of 
differentiation are linked by a cell cycle-dependent Rb-C/EBPβ interaction. Cell cycle arrest 
in G1 by L-mimosine inhibited differentiation-induced C/EBPβ-DNA-binding activity and 
Rb phosphorylation. However, cell cycle arrest after the G1/S transition by aphidicolin or 
nocodazole did not prevent C/EBPβ-DNA-binding activity or Rb phosphorylation. 
Furthermore, hypophosphorylated Rb and C/EBPβ coimmunoprecipitated, whereas 
phosphorylated Rb and C/EBPβ did not. Electrophoretic mobility shift assays demonstrated 
that recombinant hypophosphorylated Rb decreased C/EBPβ-DNA-binding activity and that 
Rb overexpression inhibited C/EBPβ-induced transcriptional activation of a C/EBPβ-
promoter-luciferase reporter gene. We conclude that C/EBPβ-DNA-binding activity is 
regulated by its interaction with hypophosphorylated Rb, thereby linking the progression of 
the cell cycle to the initiation of differentiation during 3T3-L1 adipogenesis. 
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B. Introduction 
 The obesity epidemic has heightened the demand for effective prevention and treatment 
methods. An insight into the molecular mechanisms underlying adipogenesis may lead to the 
development of effective strategies for reducing the prevalence of obesity. Much of what is 
known about adipocyte development has been elucidated from established cell lines that 
mimic adipocyte proliferation and differentiation in vivo [181]. The 3T3-L1 preadipocyte 
cell line provides a well-characterized model for the study of adipocyte-specific terminal 
differentiation [27, 182-185]. On reaching confluence, 3T3-L1 preadipocytes growth arrest at 
the G0/G1 cell cycle boundary. The addition of 1-methyl-3-isobutylxanthine (M), 
dexamethasone (D), and a pharmacological dose of insulin (I) to serum-containing medium 
(MDI protocol) concurrently activates two different processes: 1) the synchronous reentry of 
preadipocytes into the cell cycle, and 2) the initiation of differentiation. Whereas the role of 
the differentiation pathway is well characterized, the role of the cell cycle during 3T3-L1 
preadipocyte differentiation is poorly understood. 
 Progression of the cell cycle from G1 to S phase is regulated by the phosphorylation 
status of the retinoblastoma protein Rb. In G1, hypophosphorylated Rb binds and sequesters 
transcription factors that are required for the expression of genes necessary for DNA 
synthesis [41, 42]. Rb phosphorylation at the G1/S boundary results in its dissociation from 
these transcription factors and triggers cell cycle progression. Rb not only binds transcription 
factors involved in cell cycle progression, it also interacts with transcription factors involved 
in differentiation [39, 44, 45]. Rb has been shown to bind to members of the 
CCAAT/enhancer binding protein (C/EBP) family of transcription factors [37, 38, 46].  
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 Transcription factors in the C/EBP family function in a cascade-like manner to activate 
adipogenesis [25, 26]. The MDI protocol induces the synthesis of C/EBPβ and C/EBPδ, 
which prime the differentiation pathway [26]. C/EBPβ and C/EBPδ activate the synthesis of 
two critical adipogenic transcription factors, peroxisome proliferator-activated receptor-γ and 
C/EBPα, which are required for the expression of adipocyte genes. Whereas C/EBPβ and 
C/EBPδ are synthesized and translocated to the nucleus within 4 h after the induction of 
differentiation, they do not bind to DNA for another 8 h [30]. This delay in DNA-binding 
activity is not well characterized. 
 Previous studies [186] have suggested that C/EBPβ-DNAbinding activity may be linked 
to cell cycle progression during differentiation. Preadipocytes induced to differentiate in the 
presence of a G1 cell cycle inhibitor, expressed C/EBPβ but had decreased C/EBPβ-DNA-
binding activity and decreased C/EBPβ-mediated transactivation of a reporter gene [186]. In 
this report, we show that C/EBPβ acquires the ability to bind to DNA in a cell cycle-
dependent manner (after the G1/S transition). Importantly, we demonstrate that although 
hypophosphorylated Rb associates with C/EBPβ, phosphorylated Rb does not. We also show 
that Rb inhibits C/EBPβ-DNA binding activity in vitro and overexpression of Rb prevents 
C/EBPβ-mediated transactivation of a C/EBPα-promoter-reporter gene. These studies 
suggest that Rb is a critical regulator of C/EBPβ-DNA binding activity during the early 
stages of 3T3-L1 adipogenesis. 
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C. Materials and methods 
 Materials. L-Mimosine, aphidicolin, and nocodazole were obtained from Cal-Biochem 
(San Diego, CA). Aprotinin, leupeptin, antipain, benzamidine,chymostatin, and pepstatin-A 
were purchased from Sigma-Aldrich (St. Louis, MO). C/EBPβ mouse monoclonal antibody 
was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The Rb monoclonal 
antibody was purchased from PharMingen (San Diego, CA). The C/EBPβ rabbit polyclonal 
antibody was generously provided by Dr. M. Daniel Lane (Johns Hopkins University). 
Recombinant full-length Rb and a truncated Rb protein, p56Rb (amino acids 379–928), were 
purchased from QED Bioscience (San Diego, CA). The recombinant truncated Rb p25Rb 
(amino acids 773–928) was purchased from Upstate (Charlottesville, VA). 
 Cell culture. 3T3-L1 preadipocytes were cultured in Dulbecco’s Modified Eagle medium 
(DMEM) containing 10% calf serum (CS) until confluence and then maintained for 48 h (day 
0). Preadipocytes were then maintained in CS (time 0) or were induced to differentiate with 
0.5 mM 3-isobutyl-1-methylxanthine, 1 μM dexamethasone, and 
1 μg/ml insulin in DMEM containing 10% fetal bovine serum for 48 h (MDI protocol). 
Where indicated, cell cycle inhibitors (5 μM aphidicolin, 500 μM mimosine, or 10 μM 
nocodazole) were added at the time of induction. 
 Immunoblot analysis. 3T3-L1 preadipocyte whole cell lysates were prepared as 
previously described [187]. Protein concentrations were determined and protein (50 μg) was 
subjected to SDS-PAGE and transferred to Immobilon-P membranes (Millipore). The 
membranes were incubated with antisera as indicated, followed by incubation with a 
peroxidase-conjugated secondary antibody. Proteins were visualized by enhanced 
chemiluminescence (Amersham Pharmacia Biotech).  
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 Nuclear extract preparation. Nuclear extracts were prepared from 3T3-L1 
preadipocytes as described previously [188, 189]. Cells were washed with PBS and scraped 
in a hypotonic lysis buffer containing 20 mM Tris, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 1 
mM dithiothreitol (DTT), and 2 μl/ml of protease inhibitor cocktails PIC I and PIC II. PIC I 
contains (in mg/ml) 1 leupeptin, 1 antipain, and 10 benzamidine in 1 aprotinin in distilled 
water. PIC II contains 1 mg/ml chymostatin and 1 mg/ml pepstatin-A in dimethyl sulfoxide. 
Nonidet P-40 (NP-40) was added to a final concentration of 1%. The samples were Dounce 
homogenized and centrifuged at 2,200 x g for 5 min at 4°C. The crude nuclear pellet was 
resuspended in hypotonic lysis buffer and centrifuged at 2,200 x g for 5 min at 4°C. The 
pellet was resuspended in a nuclei storage buffer containing 40% glycerol, 1 M Tris pH 8.0, 
3 mM MgCl2, 1 mM DTT, and 2 μl/ml PIC I and PIC II and was centrifuged at 6,500 x g for 
10 seconds at 4°C. The pellet was resuspended in NUN buffer (0.3 M NaCl, 1 M urea, 1% 
NP-40, 25 mM HEPES, pH 7.9, 1 mM DTT, and 2 μl/ml PIC I and PIC II), incubated on ice 
for 30 min, and centrifuged at 14,000 x g for 10 min at 4°C. Supernatants were collected and 
glycerol was added to a final concentration of 10%. 
 EMSA. A [32P]-labeled double-stranded oligonucleotide (20 bp), corresponding to the 
C/EBP site in the C/EBPα promoter was used for EMSA. The labeled probe and 10 μg of 
nuclear protein were incubated on ice for 15 min and then subjected to nondenaturing PAGE. 
Protein-DNA complexes were visualized by autoradiography. For gel supershift experiments, 
2.5 μg of the indicated antibody were added to the nuclear protein 15 min before the addition 
of the labeled probe. All recombinant Rb proteins were resuspended in a solution containing 
20 mM sodium phosphate, 200 mM NaCl, 1 mM EDTA, and 10% glycerol, pH 7.5. In 
competition experiments, 1 μg of either p56Rb or p25Rb was added to 12 μg of nuclear 
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protein 15 min before the addition of labeled probe. In dose-dependent competition 
experiments, 0.05–0.5 μg of purified, full-length recombinant Rb was added to the nuclear 
protein. Protein concentration was equalized with BSA, and the samples contained equal 
amounts of Rb diluent.  
 Immunoprecipitation. 3T3-L1 preadipocytes were washed twice in ice-cold PBS 
containing 1 mM orthovanadate, scraped in ice-cold gentle lysis buffer (25 mM Tris-HCl, pH 
7.5, 1% NP-40, 10% glycerol, 50 mM NaF, 10 mM NaH2PO4, 137 mM NaCl, 2 mM 
Na3VO4, 1 mM PMSF, and 10 μg/ml aprotinin), sonicated, and then centrifuged at 6,000 x g 
at 4°C for 20 min. Supernatants were removed, and protein concentrations were determined. 
Antibodies (10 μg/ml) to either C/EBPβ or Rb were added to protein lysates (800 μg) and 
allowed to incubate at 4°C for 1 h. Agarose beads (protein A/G PLUS-agarose beads) were 
mixed with the immunoprecipitates for 1 h at 4°C. Immunoprecipitates were recovered by 
centrifugation at 2,500 x g and washed three times with ice-cold lysis buffer. 
Immunoprecipitated proteins were dissolved in 2X Laemmli buffer, heated at 95°C for 5 min, 
subjected to SDS-PAGE, and transferred to Immobilon-P membranes (Millipore). 
Membranes were incubated with the indicated primary antibodies and visualized by 
enhanced chemiluminescence.  
 Transfection. 3T3-L1 preadipocytes were transiently cotransfected 
on day 0 by calcium phosphate co-precipitation with a C/EBPα promoter-luciferase construct 
alone [30] or with either a cytomegalovirus (CMV)-C/EBPβ expression vector (generously 
provided by Dr.M. Daniel Lane, Johns Hopkins University) and/or a CMV-Rb or a Rb 
mutant vector with a deletion corresponding to amino acid 389–580 (Rbmut) (generously 
provided by Dr. Jonathan M. Horowitz, North Carolina State University)[190]. Cells were 
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then maintained in DMEM containing 10% CS for 24 h. Differentiation was induced as 
described previously. Cell lysates were prepared 24 h after induction and assayed for 
luciferase activity, which was normalized to cells transfected with the C/EBPα-promoter-
luciferase construct alone and treated with MDI. 
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D. Results 
 C/EBPβ-DNA-binding activity correlates with Rb phosphorylation. Because both 
C/EBPβ-DNA-binding activity and cell cycle progression are induced early during 3T3-L1 
adipogenesis, we planned to determine the relationship between these two events. Day 0 (2-
day postconfluent preadipocytes) were maintained in CS (time 0) or were induced to 
differentiate, using the MDI protocol. Whole cell lysates were collected every 4 h (for 24 h) 
and subjected to immunoblot analysis with the use of an Rb antibody (Fig. 2.1A, top) or a 
C/EBPβ antibody (Fig. 2.1A, bottom). Although Rb is constitutively expressed, its activity is 
regulated by cell cycle-dependent phosphorylation. Rb is hypophosphorylated at the 0, 4, and 
8 h time points (Fig. 2.1A, top). Two bands are detected 12 h after MDI treatment as the cells 
cross the G1/S boundary: the hypophosphorylated form of Rb and a slower-migrating 
hyperphosphorylated form of Rb. The hyperphosphorylated form of Rb predominates at the 
subsequent time points. Next, we characterized C/EBPβ expression during this time period 
(Fig. 2.1A, bottom). C/EBPβ mRNA can be alternately translated to produce both 35- and 
18-kDa proteins, termed Liver Activating Protein (LAP) and Liver-Inactivating Protein, 
respectively. C/EBPβ (LAP) is expressed at maximal levels within 4 h after MDI treatment 
(Fig. 2.1A, bottom).  
 To determine the temporal pattern of C/EBPβ-DNA-binding activity in relation to the 
G1/S transition of the cell cycle, day 0 preadipocytes were maintained in CS (time 0) or were 
treated with the MDI protocol. Nuclear extracts were prepared at 6-h intervals (for 24 h) and 
subjected to EMSA with the use of an oligonucleotide corresponding to the C/EBP binding 
site of the C/EBPα promoter. C/EBPβ-DNA-binding activity increased dramatically 12 h 
after the induction of differentiation (Fig. 2.1B). Nuclear extracts incubated with a C/EBPβ-
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specific antibody supershifted the protein-DNA complex, thereby confirming that C/EBPβ 
was the predominant C/EBP isoform binding to the oligonucleotide at these time points (Fig. 
2.1B). Because both Rb phosphorylation and C/EBPβ-DNA-binding activity occur about 12 
h after induction of differentiation, we wanted to determine whether these two events link the 
cell cycle to the priming of differentiation during adipogenesis.  
 
 
Figure 2.1: Rb phosphorylation (Rb~P) coincides with CCAAT/enhancer binding 
protein beta (C/EBPβ)-DNA-binding activity. Day 0 (2-day postconfluent) 3T3-L1 
preadipocytes were induced to differentiate using the standard 1-methyl-3-isobutylxanthine, 
dexamethasone, and insulin (MDI) protocol (see EXPERIMENTAL PROCEDURES). A: 
whole cell lysates were prepared at the times indicated and subjected to SDS-PAGE and 
Western blot analysis with the use of an antibody directed against Rb (top) or C/EBPβ 
(bottom). B: 32P-labeled oligonucleotide probe containing the C/EBP binding site of the 
C/EBPα promoter was incubated with 10 μg of nuclear protein, prepared at the times 
indicated, and subjected to EMSA. Supershift analysis was performed with the use of a 
C/EBPβ-specific antibody. The data are representative of three independent experiments. 
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 Cell cycle inhibition affects C/EBPβ-DNA-binding activity. Because C/EBPβ is 
maximally expressed 4 h after the induction of differentiation but does not bind to DNA for 
another 8 h, we wanted to determine whether the delay in C/EBPβ-DNA-binding activity is 
related to cell cycle progression. Day 0 preadipocytes were maintained in 10% CS or were 
induced to differentiate with the MDI protocol in the absence or presence of various cell 
cycle inhibitors. Twenty-four hours after induction, nuclear extracts were prepared and 10 μg 
of nuclear protein were subjected to EMSA, as described under EXPERIMENTAL 
PROCEDURES (Fig. 2.2A). Whole cell lysates were also prepared 24 h after treatment and 
subjected to immunoblot analysis using either an Rb or C/EBPβ-specific antibody (Fig. 2.2B, 
top and bottom, respectively). The cell cycle inhibitor L-mimosine (a late G1 cell cycle 
inhibitor) inhibited C/EBPβ-DNA binding activity without affecting C/EBPβ expression 
(Fig. 2.2, A and B). As expected, L-mimosine treatment prevented the phosphorylation of Rb 
(Fig. 2.2B). In contrast, preadipocytes induced to differentiate in the presence of either 
aphidicolin (an agent that prevents DNA synthesis without preventing Rb phosphorylation) 
or nocodazole (an agent that arrests the cell cycle at the G2/M transition) had similar levels 
of C/EBPβ expression and C/EBPβ-DNA-binding activity as preadipocytes treated with MDI 
alone (Fig. 2.2, A and B). Rb was hyperphosphorylated in preadipocytes treated with either 
aphidicolin or nocodazole because both agents arrest the cell cycle after the G1/S transition 
(Fig. 2.2B). Cell cycle arrest by the various inhibitors was confirmed by fluorescence-
activated cell sorting analysis (data not shown).  
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Figure 2.2: C/EBPβ-DNA-binding acitivity requires G1/S transition. Day 0 3T3-L1 
preadipocytes were maintained in 10% calf serum (CS) or were induced to differentiate by 
the standard MDI protocol (MDI) in the absence or presence of L-mimosine (Mimo), 
aphidicolin (Aph), or nocodazole (Noc). A: nuclear extracts were prepared 24 h after 
treatment. Ten micrograms of nuclear protein were subjected to EMSA, as described in 
EXPERIMENTAL PROCEDURES. B: cell lysates were prepared 24 h after the various 
treatments and subjected to SDS-PAGE and Western blot analysis using Rb antisera (top) or 
C/EBPβ antisera (bottom). The results are representative of three independent experiments. 
 
 
  
 Rb and C/EBPβ interact in a cell cycle-dependent manner. Before its 
hyperphosphorylation at the G1/S transition, Rb binds and sequesters transcription factors 
required for DNA synthesis. Rb has also been shown to interact with members of the C/EBP 
family, including C/EBPβ [37, 38, 46] . Because the DNA-binding activity of C/EBPβ 
correlates with the hyperphosphorylation of Rb (Figs. 2.1 and 2.2), we wanted to determine 
whether C/EBPβ and Rb interact in a cell cycle-dependent manner. Preadipocytes are in G1 6 
h after MDI induction and have progressed beyond the G1/S transition point by 18 h [191]. 
Day 0 3T3-L1 preadipocytes were either maintained in CS (time 0) or induced to 
differentiate by the MDI protocol for 6 or 18 h. Coimmunoprecipitation assays were 
conducted with the use of a C/EBPβ-specific antibody and immunoblotted by using either an 
Rb or a C/EBPβ antibody (Fig. 2.3). Immunoprecipitation reactions yielded only 
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hypophosphorylated Rb (compare the migration pattern in the whole cell lysates with that in 
the immunoprecipitates). Immunoprecipitated C/EBPβ associates with Rb strongly at 0 and 6 
h, when Rb is hypophosphorylated, but only weakly at 18 h (Fig. 2.3), when most of the Rb 
is hyperphosphorylated. These studies suggest that the Rb-C/EBPβ interaction depends on 
the phosphorylation state of Rb. The pattern of C/EBPβ expression in whole cell lysates and 
immunoprecipitates was similar (Fig. 2.3). 
 
Figure 2.3: Rb-C/EBPβ interaction is regulated by phosphorylation of Rb.  Day 0 3T3-
L1 preadipocytes were induced to differentiate by the standard MDI protocol. Lysates were 
collected at 0, 6, and 18 h after the induction of differentiation, subjected to 
coimmunoprecipitation (IP) using a C/EBPβ-specific antibody, and immunoblotted (IB) 
using either an Rb antibody (top) or a C/EBPβ antibody (bottom). Whole cell lysates from 
the time points indicated were included as controls. The figure is representative of three 
independent experiments.  
 
  Rb decreases C/EBPβ-DNA-binding activity. Because Rb and C/EBPβ interact at 
time points when Rb is hypophosphorylated and C/EBPβ-DNA-binding activity is low, we 
wanted to determine whether unphosphorylated Rb alters C/EBPβ-DNAbinding activity. 
Two-day postconfluent 3T3-L1 preadipocytes were maintained in 10% CS (0 h) or were 
treated with MDI for 18 h; nuclear extracts were prepared as described in EXPERIMENTAL 
PROCEDURES. C/EBPβ-DNA-binding activity is maximal at 12 h and continues to be high 
18 h after induction (Fig.2.4B). Nuclear extracts from 0 and 18 h were subjected to EMSA. 
Recombinant, full-length unphosphorylated Rb protein (0, 0.05, 0.1, 0.25, and 0.5 μg) was 
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incubated with 18 h nuclear extracts and subjected to EMSA (Fig. 2.4B, lanes 2 and 5–8). 
Full-length unphosphorylated Rb decreased C/EBPβ-DNA binding activity. Because 
previous studies have demonstrated that C/EBPβ can bind to the two pocket domains (PDA 
and PDB) of Rb (Fig. 2.4A) (3), we examined the effect of truncated Rb proteins (p56Rb or 
p25Rb) on C/EBPβ-DNA-binding activity in 18 h nuclear extracts (Fig. 2.4B, lanes 3 and 4). 
The addition of p56Rb decreased C/EBPβ-DNA-binding activity, whereas p25Rb did not 
(Fig. 2.4B). These findings suggest that unphosphorylated Rb can inhibit the DNA-binding 
activity of C/EBPβ even after the G1/S transition. 
Figure 2.4: Rb decreases C/EBPβ-DNA binding activity. A: schematic representation of 
the full-length Rb protein and the Rb truncated proteins p56Rb and p25 Rb. Pocket domains A 
and B (PDA and PDB) are binding sites for C/EBPβ. B: day 0 3T3-L1 preadipocytes were 
either untreated (0 h) or were induced to differentiate by the standard MDI protocol for 18 h. 
Nuclear extracts were prepared, and 12 μg of nuclear protein were subjected to EMSA (lanes 
1 and 2). One microgram of either p56Rb or p25 Rb protein was incubated with 18 h nuclear 
extracts (lanes 3 and 4). Recombinant full-length Rb protein (0.05, 0.1, 0.25, or 0.5 μg) was 
incubated with 18 h nuclear extracts and subjected to EMSA (lanes 5-8). The results are 
representative of three independent experiments.  
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 Overexpression of Rb inhibits C/EBPβ-mediated transcription. Because association 
with Rb inhibits the DNA-bindingactivity of C/EBPβ in vitro, we wanted to determine 
whether the overexpression of Rb would inhibit C/EBPβ-mediated transcriptional activation. 
The C/EBPα-promoter contains a C/EBP binding site that mediates transactivation by 
members of the C/EBP family. To determine whether Rb can alter C/EBPβ-mediated 
transcriptional activation, 3T3-L1 preadipocytes were mock transfected or were transfected 
with the C/EBPα-promoter-luciferase reporter transgene alone or with a CMV-Rb, a Rbmut 
(deletion of the PDA domain) (27), and/or a CMV-LAP expression vector by calcium-
phosphate coprecipitation. Transfected preadipocytes were then induced to differentiate with 
MDI for 24 h. Luciferase activity was assayed 24 h after MDI induction (results are 
presented as means ±SD, n=4). Cells cotransfected with a C/EBPα promoter-luciferase 
reporter gene and a CMV-LAP expression vector resulted in approximately a threefold 
increase in luciferase activity compared with cells transfected with the C/EBPα-luciferase 
reporter gene alone (Fig. 2.5). Cotransfection of the C/EBPα-luciferase reporter gene and a 
CMV-Rb expression vector resulted in a slight inhibition of luciferase activity compared with 
the level in cells transfected with a C/EBPα-luciferase reporter gene alone. Overexpression of 
Rb inhibited the C/EBPβ-mediated transcriptional activation of the C/EBPα promoter to a 
level similar to cells transfected with the C/EBPα-luciferase reporter gene alone (Fig. 2.5). 
Transfection of an Rb expression vector (Rbmut) lacking the PDA domain (a C/EBP-binding 
site) did not inhibit C/EBPβ-mediated transcriptional activation of the C/EBPα promoter. 
Taken together, these findings suggest that Rb regulates the transcriptional activity of 
C/EBPβ by directly interacting with it and preventing DNA binding. 
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Figure 2.5: Overexpression of Rb reduces C/EBPβ-mediated transcription from the 
C/EBPα promoter.   Day 0 3T3-L1 preadipocytes were transiently cotransfected with a 
C/EBPα-promoter-luciferase (LUC) reporter alone or with either a C/EBPβ and/or an Rb 
expression vector or an Rb expression vector lacking the PDA domain of Rb (Rbmut). After 
24 h, cells were induced to differentiate by the standard MDI protocol. Luciferase activity 
was assayed 24 h after induction. Luciferase activity from transfected cells was normalized to 
the levels present in cells transfected with the C/EBPα-luciferase expression vector alone, 
which was set to one. CMV, cytomegalovirus; LAP, liver-activating protein. Data represent 
four independent experiments (means  ± SD, n = 4). 
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E.  Discussion  
 Induction of 3T3-L1 adipogenesis initiates two processes: reentry into the cell cycle 
(termed mitotic clonal expansion) and the priming of differentiation. Whereas the role of the 
priming of differentiation pathway is well characterized, the role of mitotic clonal expansion 
is poorly understood. Moreover, the requirement of mitotic clonal expansion remains 
controversial [13, 34]. Our studies were aimed at determining the relationship between 
mitotic clonal expansion and the priming of differentiation during the early stages of 
adipogenesis. Our findings suggest that these processes are linked by a cell cycle-dependent 
interaction between Rb and C/EBPβ before the G1/S transition. These findings aid in our 
understanding the temporal delay between C/EBPβ expression and C/EBPβ-DNA-binding 
activity during 3T3-L1 preadipocyte differentiation and also further elucidate the relationship 
between proliferation and differentiation.  
 A critical component of 3T3-L1 adipogenesis is the temporal expression and activation of 
C/EBPβ and C/EBPδ. Although C/EBPβ is at maximal levels 4 h after induction, it does not 
bind to DNA for another 8 h (Fig. 1) [30]. Several mechanisms have been proposed in the 
regulation of C/EBPβ activity, including conformational change, interaction with 
dimerization partners, and phosphorylation [26, 192-194]. In this report, we demonstrate that 
C/EBPβ-DNA-binding activity is also regulated by the cell cycle (Figs. 1 and 2). Our 
previous studies have shown that C/EBPβ-DNA-binding activity is inhibited in the presence 
of the calpain inhibitor ALLN, which arrests cells in G1 [186]. To determine whether calpain 
activity or cell cycle progression mediates C/EBPβ-DNA-binding activity, we employed 
another known G1 cell cycle inhibitor. Inhibition of the cell cycle in G1 by L-mimosine also 
blocked C/EBPβ-DNA binding activity even after 24 h (Fig. 2). In contrast, inhibition of the 
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cell cycle after the G1/S transition by either aphidicolin (cell cycle arrest in S phase) or 
nocodazole (arrest at G2/M) did not prevent C/EBPβ-DNA-binding activity. Because all of 
these studies were conducted 24 h after MDI induction, our findings suggests that C/EBPβ-
DNA-binding activity is cell cycle-dependent, not time dependent, during the early stages of 
adipogenesis. 
 Linking C/EBPβ-DNA-binding activity to the cell cycle further suggests a connection 
between the initiation of differentiation and cell cycle progression. Our studies demonstrate a 
cell cycle-dependent interaction between C/EBPβ and Rb (Fig. 3). Rb is a critical regulator of 
cell cycle progression at the G1/S transition. Previous studies have shown that Rb and C/EBP 
family members are able to interact in in vitro experiments [37]. While these studies 
demonstrate an interaction between Rb and C/EBP isoforms, that interaction was not 
investigated in the context of cell cycle progression. Our study is the first to examine the 
interaction between Rb and C/EBPβ as a function of the cell cycle. We propose a mechanism 
for cell cycle-mediated C/EBPβ-DNA-binding activity during 3T3-L1 adipogenesis. 
Specifically, our studies show that hypophosphorylated Rb (6 h after induction) binds to 
C/EBPβ, whereas hyperphosphorylated Rb (18 h) does not (Fig. 3). During time points when 
Rb and C/EBPβ interact, the DNA binding activity of C/EBPβ is minimal (Figs. 1 and 3). 
Conversely, maximal C/EBPβ-DNA-binding activity occurs when Rb and C/EBPβ no longer 
associate (Figs. 1 and 3). Previous studies (4) have shown that C/EBPβ is able to bind to Rb 
by interacting with the pocket domains PDA and PDB. Our studies demonstrate that 
recombinant Rb proteins that contain the pocket domains (either full-length or p56Rb) reduce 
C/EBPβ-DNA-binding activity in 18 h nuclear extracts, whereas p25Rb, which lacks both 
C/EBPβ-DNA-binding domains (PDA and PDB), does not affect C/EBPβ-DNA-binding 
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activity (Fig. 4). Because hypophosphorylated Rb interacts with many different proteins with 
varying affinities [39], relatively high concentrations of recombinant Rb proteins were used 
to alter C/EBPβ-DNA-binding activity in competition assays. The addition of full-length 
recombinant hypophosphorylated Rb reduced C/EBPβ-DNA-binding activity when the 
concentration of exogenous Rb was about 4% of the total protein in the assay (Fig. 4). 
Furthermore, we show that overexpression of Rb inhibited the C/EBPβ-induced 
transactivation of the C/EBPα-promoter-luciferase reporter (Fig. 5). Collectively, our 
findings suggest that the hypophosphorylated Rb-C/EBPβ interaction couples cell cycle 
progression with the initiation of differentiation.  
 In conclusion, this study demonstrates that hypophosphorylated Rb is a negative regulator 
of C/EBPβ-DNA binding activity during 3T3-L1 preadipocyte differentiation. These studies 
add to the growing body of evidence that demonstrate a requirement for mitotic clonal 
expansion during 3T3-L1 adipogenesis. Our findings also provide evidence that clonal 
expansion participates in the temporal regulation of transcriptional effects required for 
differentiation (C/EBPβ-DNA-binding activity). These studies provide a link between mitotic 
clonal expansion and initiation of differentiation. Although this study proposes a mechanism 
for the delay in C/EBPβ-DNA binding activity, further studies are required to determine the 
purpose of this delay. 
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A. Abstract 
 Objective: To investigate the sequence of events mediating inflammatory changes in 
subcutaneous and visceral adipose tissues in obesity.  
 Research Methods and Procedures:  Male C57BL/6 weanlings were fed a high fat (HF) 
or low fat (LF) diet for 16 weeks. At two-week intervals, weight, body composition, liver 
triacylglycerol content, and fasting serum concentrations of glucose, insulin, corticosterone, 
leptin, and cytokines were measured. Liver and adipose tissue (AT) from inguinal, 
epididymal, and retroperitoneal depots were studied for cytokine and chemokine gene 
expression. ATs were studied for adipocyte size and macrophage infiltration.  
 Results: Compared to LF diet, the HF diet resulted in a higher body weight after 2 weeks 
and more body fat after 6 weeks. At week 8 in HF mice, epididymal adipocyte size peaked. 
Also, TNFα, IL-1β, IL-6 mRNA transcripts in the retroperitoneal AT increased, and MCP-1 
and MIP-1α mRNAs in all AT depots increased. Inguinal MCP-1 and MIP-1α expression 
was transient, but epididymal and retroperitoneal expression persisted. At week 10, the HF 
mice had liver steatosis, higher serum leptin concentrations and the initial formation of 
macrophage aggregates in epididymal AT; aggregates were never significant in inguinal AT. 
At week 14, in HF mice had higher fasting serum insulin concentrations relative to the LF 
mice.   
 Discussion: Before significant hormonal or metabolic changes associated with obesity 
occur, epididymal adipocyte hypertrophy induced by a HF diet coincides with increased 
MCP-1 and MIP-1α mRNA in this depot, and precedes macrophage aggregation. In contrast, 
inguinal adipose tissue MCP-1 and MIP-1α gene expression is transient and is not followed 
by macrophage aggregation despite the presence of similar size adipocytes.  
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B. Introduction 
 Obesity, in both humans and animals, induces a state of low-grade chronic inflammation 
[133, 138, 195-198]. Attention has focused on the liver and adipose tissue as sources of the 
inflammatory mediators which exacerbate the health consequences of obesity [99, 199-201]. 
Within the adipose tissue, macrophages are reported to be the predominant source of most 
inflammatory cytokines and chemokines [124, 135, 202]. The macrophage infiltrate in the 
adipose tissue of lean C57BL/6 mice is rare and dispersed, while in overtly obese mice, the 
macrophages are plentiful [124], and aggregate around non-viable adipocytes [134]. Several 
studies have shown that in adipose tissue, adipocytes and macrophage express mRNA for 
TNFα, IL-1β and IL-6 [139, 140, 142] [124, 135, 203, 204], which are the prototypic 
inflammatory cytokines studied in association with obesity. The autocrine/paracrine effects 
of these cytokines include impairing local insulin signaling and facilitating the recruitment 
and activation of macrophages in the adipose tissue. Additionally, the chemokines MCP-1 
and MIP-1α are elevated in the adipose tissue of obese animals and humans [128, 135, 202, 
205, 206]. These chemokines may increase monocyte and macrophage trafficking to the 
tissue.  
 While there are clear differences between visceral adipose tissue and subcutaneous 
adipose tissue with regard to their metabolic profiles and health risks [207-209], no studies 
have examined their differences in the development of inflammation. Therefore, this study 
was designed to determine if there are inflammatory differences between visceral and 
subcutaneous adipose tissue in lean and diet-induced obese mice. In addition, rather than 
examining mice at one time point, we studied mice at numerous time points during induction 
of obesity to better determine the sequence of events that leads to the inflammatory state. 
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Every 2 weeks for 16 weeks, we measured adipocyte size, liver triacylglycerol (TAG) 
content, liver and adipose tissue mRNA for inflammatory cytokines and chemokines and the 
presence of adipose tissue macrophages. 
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C. Materials and methods 
 Animals and diets. Four-week old male C57BL/6 mice purchased from Jackson Labs 
(Bar Harbor, ME) were housed 4 per cage and were fed Purina standard laboratory chow for 
4 days. At week 0 of the study, mice were randomized to receive either a high fat (HF) or 
low fat (LF) diet. Diets were purchased from Research Diets (New Brunswick, NJ). The HF 
diet (D01060502) contained 20% kcal from protein, 35% carbohydrate (corn starch), and 
45% fat (soybean oil and lard). The LF diet (D01060501) contained 20% kcal from protein, 
70% carbohydrate (corn starch), and 10% fat (soybean oil and lard). All experiments in this 
study used four to eight mice per group on each of the days examined. Animals were 
maintained under the strict animal care guidelines outlined by the Animal Welfare Act and 
the NIH “Guide for the Care and Use of Laboratory Animals”. The animal facility is fully 
accredited by the AAALAC and all mouse procedures were approved by the UNC at Chapel 
Hill Institutional Animal Care and Use Committee.  
 Body composition. At baseline (week 0) and at 2 week intervals for 16 weeks, cages 
were randomly selected and the mice were weighed and their body composition was 
analyzed by PIXImus® densitometer (GE Lunar Corporation; Waukesha, WI), to measure 
whole body (subcranial) lean and fat tissue.  
 Fasting serum glucose, insulin, corticosterone, leptin, and cytokine concentrations. 
Following a 4-hour fast (0400-0800) mice were killed by cervical dislocation and blood was 
collected from a cardiac puncture. Serum was separated by centrifugation (2000 x g; 15 min) 
and stored at –20°C. Serum glucose was measured with Wako Glucose C2 kit. (Wako 
Diagnostics, Richmond, VA). Serum insulin was measured by ELISA (LINCO Research, St. 
Charles, MO). Serum corticosterone was measured by RIA (MP Biomedical, Solon, OH). 
 57
Serum leptin was measured by ELISA (R&D Systems, Minneapolis, MN). Serum cytokines 
were measured by 10-plex Antibody Bead Kit (Biosource, Camarillo, CA).  
 Measurement of liver triacylglycerol content. Approximately 100 mg liver tissue was 
homogenized in tissue lysis buffer. Lipids were extracted with 2:1 (v/v) chloroform: 
methanol and final extracts were dissolved in 3:1:1 (v/v/v) tert-butanol, methanol, Triton X-
100. Triacylglycerol concentrations were measured using and enzymatic colorimetric assay. 
Values are expressed as milligrams of TAG per gram of liver tissue. The analysis of iver 
triacylglycerol was limited to 14 weeks of dietary intervention.  
 Quantitation of liver and adipose tissue gene expression. Liver and white adipose 
tissue (AT) from the inguinal, epididymal and retroperitoneal depots were flash frozen in 
liquid nitrogen and stored at −80°C. Total RNA from adipose tissue and liver was isolated 
using the RNeasy Lipid Tissue-, and RNeasy Mini kits (Qiagen, Valencia, CA), respectively. 
Reverse transcription was carried out using Superscript II First Strand Synthesis kit 
(Invitrogen, Carlsbad, CA) using oligo (dT) primers. Relative expression of mRNA 
transcripts for murine TNFα, IL-1β, IL-6, MCP-1, MIP-1α and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were determined using quantitative RT-PCR, with fluorescent 
reporters detected by a Bio-Rad iCycler PCR machine. Primers and probes were designed 
using Primer Express 1.5 (Applied Biosystems, Foster City, CA). The relative mRNA 
transcript expressions for GAPDH were determined for all samples and were used to 
normalize gene expression. All data are expressed as fold induction of mice fed the HF diet 
relative to mice fed the LF diet. 
 Immunohistochemistry. Paraformaldehyde-fixed, paraffin-embedded inguinal and 
epididymal adipose tissues were cut in 5μm sections. Sections were deparaffinized, 
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rehydrated, and endogenous peroxidases were quenched with 3% H2O2 for 20 min. Antigen 
retrieval was performed using Retrievagen A (BD Pharmingen, San Jose, CA). Endogenous 
biotin was blocked with diluted egg white for 20 min, rinsed with dH2O, and remaining 
avidin was quenched with 5% milk. Non-specific binding was blocked with 10% goat serum 
with 1% BSA in TBS. On each slide, the negative control was incubated in diluent, and the 
other tissue section was incubated with F4/80 antibody (Abcam, Cambridge, MA) overnight 
at 4°C. After washing in TBS, biotinylated goat anti-rat secondary antibody (BD 
Pharmingen) was applied for 30 min, followed by streptavidin-HRP, DAB substrate solution, 
and then counterstained with hematoxylin. Average adipocyte cross sectional area was 
determined from an average of 500 adipocytes in ≥5 fields at 20x magnification using ImageJ 
software. Macrophage formations of ‘ring’ aggregates were counted on the entire cross 
section under 40x magnification, A ‘ring’ aggregate was defined as DAB-positive stained 
macrophages encircling ≥ 75% of an adipocyte’s circumference.  
 Statistical analysis. All data were analyzed using JMP 6© Statistical Software (SAS 
Institute Inc. Cary, NC). Data were analyzed by 2-way ANOVA. When the F-test was 
significant, data were analyzed using Wilcoxon rank scores. Differences were considered 
significant at *p≤ 0.05; ** p≤ 0.001. Values are expressed as means ± SE of 4-8 mice/group.  
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D. Results 
 Mice fed a high fat diet become obese. As expected, the HF diet induced obesity during 
the 16 week study. After only 2 weeks on the HF diet, the mice weighed significantly more 
than the LF group, and the difference in weight between the two groups increased over time 
(Fig. 3.1A). At week 12, the HF group weighed 20% more than the LF group. By week 16, 
the HF group had gained nearly twice as much weight as the LF group. Body composition 
determination by PIXImus™ revealed that while the groups had similar lean body mass (data 
not shown), the HF group had a higher percent body fat at week 6 (Fig. 3.1B). By week 8, the 
HF group had twice the body fat mass of the LF group. Relative to the LF group, the HF 
group gained 3.3 times more fat mass during the 16 week study. Thus, as previously shown 
[85, 135, 210], feeding a HF diet to C57BL/6 mice induces obesity. 
Figure 3.1: Increase in body weight and body fat during 16 weeks of HF feeding.  (A) 
Body weight (grams) of male mice receiving either a HF or LF diet. Values are expressed as 
mean ± SEM, n = 12-16. (B) Percent body fat as determined by PIXImus™. Values are 
expressed as mean ± SEM, n = 6-8. *p≤0.05; **p≤0.001 of HF relative to LF group, 
Student’s t test.  
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 Elevated fasting serum glucose and insulin concentrations in mice fed a HF diet. 
Obesity and inflammation are associated with glucose intolerance and insulin resistance; 
therefore, we measured fasting serum glucose and insulin concentrations in the HF and LF 
groups. As shown in Fig. 3.2A, the mean fasting glucose concentrations in the HF group 
exceeded 8.3 mmol/L (~ 150 mg/dl) at each time point. This is above the fasting glucose 
concentrations found in the LF mice, as has been previously described [211, 212]. Because 
corticosterone is known to increase serum glucose and counteract the effects of insulin, we 
measured serum corticosterone concentrations. There were no differences in fasting serum 
corticosterone levels between the groups (data not shown). Fasting serum insulin 
concentrations were similar between the groups through week 12 (Fig. 3.2B). However, at 
weeks 14 and 16, the respective fasting serum insulin in the HF group was 4-, and 6-fold 
higher than the LF group. Furthermore, the homeostatic model assessment for insulin 
resistance (HOMA-IR) was higher in the HF group relative to the LF group at weeks 14 and 
16 (Fig. 3.2C).  
 Increased fasting serum leptin concentrations in mice fed a HF diet. It has been well 
established that the serum concentration of leptin is increased in obesity. Leptin not only 
functions in energy homeostasis, it is also important in the inflammatory response. By week 
10 of the study, mice in the HF group had elevated fasting serum leptin concentrations (Fig. 
3.2D). 
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Figure 3.2: Changes in metabolic and hormonal parameters during the 16 weeks of HF 
feeding. (A) Fasting serum glucose (mmol/L); (B) fasting serum insulin (pmol/L), (C) 
homeostatic modeling assessment of insulin resistance (HOMA-IR); (D) fasting serum leptin 
(nmol/L) in mice receiving a HF or LF diet. Mice were fasted for 4 hours (0400-0800) prior 
to blood draw. Values are expressed as means ± SEM, n = 6-8. *p≤0.05; **p≤0.001 of HF 
relative to LF group, Student’s t test. 
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 Increased liver triacylglycerol is not associated with increased liver cytokine or 
chemokine mRNA. Obesity and several metabolic disturbances involving inflammation are 
associated with hepatic steatosis. Therefore, we measured the hepatic triacylglycerol (TAG) 
content in mice receiving either the LF or HF diet. When compared to the LF group at week 
6, the HF group had significantly more liver TAG (Fig. 3.3A). At week 10, over 5% of the 
liver weight in the HF group was TAG, indicating steatosis. By week 14, relative to the LF 
group, the HF group had nearly 4 times more liver TAG. To determine whether or not 
inflammatory cytokines and chemokines were being expressed in the livers of mice on the 
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HF diet, we measured TNFα, IL-1β, IL-6, MCP-1 and MIP-1α gene expression by qRT-PCR 
(Fig. 3.3). Statistical analysis by 2-way ANOVA revealed that there was not a main effect of 
diet on cytokine and chemokine transcript gene expression. Therefore, changes in cytokine 
and chemokine transcript expression in the liver are likely due to an effect of age rather an 
effect of obesity. To determine if serum cytokine concentration was increased in the HF 
group, we analyzed the serum of both groups for proinflammatory cytokines. Serum TNFα, 
IL-1β and IL-6 were below the detection limit for the assay (data not shown). 
 
Figure 3.3: Hepatic triacylglycerol content and inflammatory cytokine and chemokine 
gene expression increases during HF feeding. Mean hepatic triacylglycerol content. Data 
are expressed as milligrams of triacylglycerol per gram of liver tissue ± SEM. *p≤0.05; 
**p≤0.001 of HF relative to LF group by Student’s t test.  Relative gene expression for liver 
cytokines and chemokines: TNFα, IL-1β, IL-6, MCP-1, and MIP-1α. Target gene expression 
was normalized to GAPDH gene expression. Values represent the mean of the HF group 
expressed as fold change relative to the mean of the LF group ± SEM, n = 6-8. Two-way 
ANOVA indicated that there was not a main effect of diet. 
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 Differences in the onset of increased adipocyte size are depot-dependent in mice fed 
the HF diet. Hepatic steatosis, and increased fasting serum insulin and leptin concentrations 
are correlated with obesity and increased visceral adipocyte size [213-215]. Although 
visceral adipose tissue is often studied in obesity, much less is known about subcutaneous 
adipose depots. Therefore, during the study we measured the mean cross-sectional area of 
adipocytes in inguinal (subcutaneous) and epididymal (visceral) adipose tissue. Throughout 
the study, the inguinal adipose depot from mice on the HF diet displayed more variability in 
adipocyte size. At week 16, the inguinal adipocytes of mice fed the HF diet were 
significantly larger than adipocytes from mice fed the LF diet (Fig. 3.4A). In contrast, the 
epididymal adipocytes of the HF group were significantly larger than the LF group at week 8, 
when they reached a plateau in size (Fig. 3.4B).  
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Figure 3.4:  Mean adipocyte cross sectional area of mice receiving either a HF diet or 
LF diet. (A) Inguinal and (B) epididymal adipocyte cross sectional area (µm2) in mice 
receiving a HF diet or LF diet. Values represent the mean ± SEM, n = 4-6. *p≤0.05 of HF 
group relative to the LF group, Kruskal-Wallis test. (C) Representative histological sections 
of inguinal (top panel) and epididymal (bottom panel) adipose tissue from mice after 0, 8 and 
16 weeks of HF feeding. Scale bar is 50 μm; magnification X20.  
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 Inflammatory cytokine mRNA levels vary by adipose tissue depot in mice fed a HF 
diet. Increased adipocyte size is positively correlated with increased expression of several 
inflammatory mediators [214]. However, because adipose tissue displays depot-specific 
metabolic characteristics, we measured cytokine gene expression in both subcutaneous (SQ) 
and visceral (V) depots: inguinal (SQ); epididymal (V), and retroperitoneal (V). By week 8, 
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the amount of mRNA transcripts for TNFα, IL-1β, and IL-6 were significantly higher in the 
retroperitoneal adipose tissue of the HF fed group relative to the LF fed group (Fig. 3.5). In 
contrast, in the inguinal and epididymal adipose depots, none of the cytokine mRNA 
concentrations were elevated.  
 
Figure 3.5:  Relative abundance of cytokine mRNA in subcutaneous and visceral 
adipose tissue of mice receiving a HF diet. TNFα gene expression (top row) in inguinal 
(left), epididymal (center), and retroperitoneal adipose tissue (right column). IL-1β gene 
expression (center row) in inguinal (left), epididymal (center), and retroperitoneal adipose 
tissue (right column). IL-6 gene expression (bottom row) in inguinal (left), epididymal 
(center), and retroperitoneal adipose tissue (right column). Values represent the mean of the 
HF group expressed as fold change relative to the mean of the LF group ± SEM, n = 6-8. 
*p≤0.05; **p≤0.001 of HF relative to LF group, Kruskal-Wallis test.  
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 Inflammatory chemokine mRNA levels vary by adipose tissue depot in HF fed mice. 
In addition to adipose tissue of obese mice and humans producing inflammatory cytokines, 
inflammatory chemokines, such as monocyte chemotactic protein-1 (MCP-1) and 
macrophage inflammatory protein-1α (MIP-1α) are also elevated [128, 135, 202, 205, 206]. 
We found that, as for inflammatory cytokine expression, chemokine expression in the AT 
was also increased in mice fed the HF diet. However, although proinflammatory changes 
were limited to the retroperitoneal depot, the increase in chemokine mRNA transcripts for 
MIP-1α and MCP-1 occurred in all 3 depots. As shown in Figure 3.6, the pattern of gene 
induction differed between the subcutaneous and visceral adipose tissue. In the inguinal 
adipose tissue, the increase in chemokine gene expression was transient. In the visceral 
adipose tissue of the mice fed the HF diet, MCP-1 and MIP-1α gene expression was elevated 
at week 8 and persisted through week 16.  
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Figure 3.6: Relative abundance of chemokine gene expression in subcutaneous and 
visceral adipose tissue of mice receiving a HF diet. MCP-1 gene expression (top row) in 
inguinal (left), epididymal (center), and retroperitoneal adipose tissue (right column).  MIP-
1α gene expression (bottom row) in inguinal (left), epididymal (center), and retroperitoneal 
adipose tissue (right column). Each data point represents the mean of the HF group expressed 
as fold change relative to the mean of the LF group, ± SE of 6-8 mice. *p≤0.05; **p≤0.001 
of HF relative to LF group, Kruskal-Wallis test.  
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 Macrophage infiltration occurs after chemokine gene expression in epididymal AT. 
MCP-1 and MIP-1α are chemoattractants for macrophages. Although several studies have 
demonstrated macrophage infiltrate in the visceral AT of obese animals and humans [124, 
135] no studies have examined macrophage infiltration in different AT depots over time. In 
the epididymal AT, significant macrophage accumulation began at week 10 in mice fed the 
HF diet (Fig. 3.7A). Importantly, the macrophage infiltration follows the increase in 
chemokine gene expression (week 8). In contrast, in the inguinal AT, were there was no 
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sustained upregulation of chemokine expression, no significant macrophage accumulation 
occurred, even after 16 weeks on the HF diet.  
 
Figure 3.7:  Macrophage formations of ‘ring’ aggregates in adipose tissue of mice fed a 
HF or LF diet for 16 weeks. (A) Macrophage ‘ring’ aggregates per 500 adipocytes in 
inguinal (ing) and epididymal (epid) adipose tissue of HF and LF groups. A ‘ring’ was 
defined as DAB-positive stained macrophages encircling ≥ 75% of an adipocyte’s 
circumference. Mean ± SEM. n = 4-6. *p<0.05 of HF relative to LF group, Kruskal-Wallis 
test. (B) Immunohistochemical staining of epididymal adipose tissue F4/80+ macrophage 
‘ring’ aggregates (arrows) after 8, 10 and 16 weeks of HF feeding. Scale bar is 50 μm; 
magnification x 20. 
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 Timing of hormonal and metabolic changes. Figure 3.8 summarizes the onset of 
hormonal and metabolic changes and inflammation in various adipose tissue depots during 
16 weeks of HF feeding. 
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Figure 3.8: Timeline of changes in metabolic, hormonal and liver characteristics, and 
the onset of inflammation in adipose tissue of mice receiving a HF diet relative to mice 
receiving the LF diet. Abbreviations: R = retroperitoneal adipose tissue; I = inguinal 
adipose tissue; E = epididymal adipose tissue.  
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E.  Discussion 
 Adipose tissue’s contribution to a state of chronic low-grade inflammation during obesity 
has recently received much attention [133, 138, 195, 196, 198]. The findings that increased 
numbers of macrophages were in the visceral adipose tissue of obese humans and animals 
contributed to the idea that the coincident increase in inflammatory mediators was derived 
from the infiltrating macrophages. Because AT depots are known to have disparate metabolic 
profiles [207, 208], we reasoned that the individual depots may also have differences in 
macrophage accumulation and inflammatory profiles. 
 To study inflammation in AT, we utilized the well-characterized C57BL/6 model of diet-
induced obesity. C57Bl/6 mice fed a HF diet have previously been shown to consume more 
calories than mice on a LF diet, and to become obese [216]. Mice fed either a HF or LF diet 
were studied at 2-week intervals for 16 weeks. Metabolic and hormonal changes induced by 
the HF diet were determined by measuring fasting serum glucose, insulin and leptin 
concentration, and liver TAG content. As previously demonstrated [211, 212], elevated 
fasting serum glucose concentration occurred soon after starting the high fat diet (within 2 
weeks) without a consequent increase in fasting serum insulin concentration. Toye et al. 
showed that C57BL/6 mice with normal insulin sensitivity have impaired glucose-stimulated 
insulin secretion [211]. In our study, fasting serum insulin concentrations and HOMA-IR 
values were not elevated in the HF group until week 14, which is consistent with other 
reports [212, 217]. Although we assessed insulin resistance using HOMA-IR, and not using 
the hyperinsulinemic-euglycemic clamp or the frequently sampled intravenous glucose 
tolerance test that are widely considered to be more accurate, HOMA-IR has been validated 
as a surrogate marker of insulin resistance in several studies and compares reasonably well 
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with clamp data [218-221]. Also, as expected [217], fasting serum leptin concentrations in 
the HF mice were greatly increased by week 10.  
 Elevated liver triacylglycerol (TAG) concentratons have been reported in diet-induced 
obese mice [120]; therefore, we measured liver TAG content over time. In hepatic steatosis, 
TAG comprises 5% or more of the liver weight. While the HF group had higher hepatic TAG 
content by week 6, the onset of steatosis occurred at week 10. Therefore, steatosis, which 
coincided with elevated fasting serum leptin concentrations, occurred prior to the increase of 
fasting serum insulin concentrations. Because hepatic steatosis may induce the expression of 
inflammatory cytokines [122] and chemokines, we measured hepatic cytokine and 
chemokine gene expression. Relative to mice consuming the LF diet, mice consuming the HF 
diet did not have increased TNFα, IL-1β, IL-6, MCP-1, or MIP-1α mRNA transcripts. Cai et 
al. reported that in diet-induced obese mice, liver TNFα and IL-1β mRNA increased 3-fold, 
and IL-6 increased 6-fold increase in hepatic IL-1β and IL-6 mRNA, respectively during 
their study of diet-induced obese mice [122]. The differences between the results of our 
studies may be due to differences in experimental design, such as the choice of control diet 
(e.g. the chow diet used for the LF mice in the Cai et al. study normally contains 4% fat vs. 
10 % fat in our purified LF diet). 
 Although increased serum concentrations of inflammatory cytokines have been reported 
in humans and genetic animal models of obesity [222-226], in our diet-induced obese mice, 
serum cytokine concentrations were below the detection limit for the assay (assay sensitivity 
for TNFα ≥ 5 pg/ml; IL-1β ≥ 10 pg/ml; IL-6 ≥ 10 pg/ml). Lack of serum cytokines in diet-
induced obese mice was also reported by Weisberg et al. (12), with the exception of very low 
concentrations of IL-6 (8 pg/ml).  
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 Previous studies have demonstrated increased mRNA transcripts for inflammatory 
chemokines in the visceral adipose tissue of mice fed a HF diet [120, 205, 227]. Two studies 
have examined MCP-1 and MIP-1α during the development of inflammation in diet-induced 
obese mice. Xu et al. reported that C57BL/6 mice fed a HF diet for 16 weeks have increased 
mRNA levels for MIP-1α and MCP-1 in their epididymal adipose tissue [135]. However, 
inguinal and retroperitoneal adipose tissues were not examined. Chen et al. designed a study 
to avoid age-related effects of the diet [227]. They demonstrated increased MCP-1 mRNA 
levels in both inguinal and epididymal AT in 4 month old mice after 1 week of HF feeding. 
The Chen et al. study differed from our study in the age of the mice when the diet was 
introduced (12-15 week old mice vs. 4 week old mice), as well as the percent fat in the LF 
and HF diets (5% vs 10% LF and 59.4% vs 45% HF). In our study, we examined 3 AT 
depots (inguinal, epididymal and retroperitoneal) for MCP-1 and MIP-1α the gene 
expression. In contrast to Chen et al., we found no expression of these chemokines until week 
8 on the HF diet, at which time all 3 depots had increased expression of mRNA for both 
MCP-1 and MIP-1α. Interestingly, the subcutaneous AT expressed increased mRNA for 
these chemokines only at week 8, whereas the two visceral AT depots had elevated mRNA 
levels at weeks 8 through 16. The highest induction occurred in the retroperitoneal AT. By 
week 16, although mRNA levels for MCP-1 and MIP-1α were decreased in the 
retroperitoneal compared to week 8 values, the level of mRNA expression in the 
retroperitoneal was similar to the level in the epididymal AT. Thus, although both 
epididymal and retroperitoneal AT are visceral depots, their pattern of chemokine gene 
expression differs, suggesting that not all visceral depots are alike. 
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 In addition to chemokines, increased mRNA levels for cytokines has been demonstrated 
in the visceral adipose tissue from obese rodents and humans [139, 228, 229]. Until quite 
recently, the various intraabdominal adipose tissue depots have been collectively referred to 
as visceral adipose tissue, therefore, distinctions among mesenteric, perigonadal (epididymal 
or parametrial) and retroperitoneal depots were not made. Recently, the perigonadal depot 
has received more attention than the retroperitoneal adipose tissue. Indeed, very little is 
known about cytokine gene expression in the retroperitoneal depot. In obese rats, Morin et al. 
reported that the retroperitoneal adipose tissue expresses more TNFα mRNA than the 
epididymal depot [230]. We are the first to report increased gene expression of the 
inflammatory cytokines TNFα, IL-1β and IL-6 in the retroperitoneal adipose tissue of diet-
induced obese mice. In contrast to the increased gene expression of inflammatory cytokines 
in the retroperitoneal depot, the epididymal depot did not express any of these cytokines. 
Furthermore, the subcutaneous adipose tissue did not upregulate the expression of the 
inflammatory cytokines. 
 What induces the AT to express proinflammatory cytokines and chemokines in mice fed 
the HF diet?  One proposal is adipocyte size. It has been demonstrated that the expression of 
inflammatory chemokines is greater in larger adipocytes compared to smaller adipocytes 
[231]. In our study, the inflammatory gene expression in the epididymal adipose tissue 
coincided with a plateau in the size of the adipocytes in the HF group. Proposed mechanisms 
of the association between adipocyte hypertrophy and inflammation include increased shear 
stress [232], reactive oxygen species [233, 234], impaired insulin signaling [235-237], and 
hypoxia-induced cytokine gene expression [238]. However, our study suggests that the size 
of the adipocyte is not the primary driving force for the induction of pro-inflammatory 
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mediators. We measured adipocyte size in two different adipose depots, representing 
subcutaneous (inguinal) and visceral (epididymal) depots. Each of these depots had unique 
pro-inflammatory characteristics, independent of adipocyte size. Thus, we found that 
although the subcutaneous inguinal and the visceral epididymal adipocytes of the HF mice 
increased equivalently in size over time, the subcutaneous adipose tissue did not sustain 
elevated levels of mRNA for MCP-1 and MIP-1α. Studies are underway to determine 
whether or not retroperitoneal adipocyte size is correlated with inflammatory cytokine and 
chemokine gene expression. At the writing of this manuscript, our data do not support the 
hypothesis that adipocyte size caused an upregulation of these genes. 
 Given the increased gene expression of macrophage chemoattractants in mice fed the HF 
diet, we looked for the presence of macrophage infiltration in subcutaneous and visceral 
adipose tissue. We found that macrophages began to aggregate in the epididymal adipose 
tissue at week 10, reaching its highest level at week 12. The macrophage infiltrate occurred 
after the increase of MIP-1α and MCP-1 mRNA, suggesting that instead of macrophages 
being responsible for the initial inflammatory signals, the adipocytes produced the pro-
inflammatory cytokines and chemokines prior to macrophage arrival. Related to the lack of 
sustained chemokine production by the subcutaneous adipose tissue in the HF group, we 
found no significant increase in macrophage aggregation in this depot. This dramatically 
contrasts with the visceral fat, which had an increase in macrophage aggregation that 
occurred after the increase in chemokine gene expression. It has been suggested that 
macrophages may be present in the AT tissue due to hypertrophy-induced adipocyte death 
[134]. Thus, as the adipocyte reaches a maximal size, it dies by necrosis and the macrophages 
surrounding the dead adipocyte are there to remove the dead/dying adipocytes. Indeed, 2 
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weeks after the onset of epididymal adipocyte hypertrophy and induction of inflammatory 
chemokines, macrophage aggregates were detected. However, the subcutaneous adipocytes 
also reached a maximal size, but macrophage infiltration was not found in this depot. Few 
studies have investigated macrophage accumulation in the subcutaneous adipose tissue. 
Weisberg et al. reported that, relative to female lean mice, male diet-induced obese mice had 
a higher percentage of F4/80+ macrophages in the subcutaneous AT at 12 weeks on a high 
fat diet [124]. Although the Weisberg et al. study did find an increase in the macrophage cell 
population in the subcutaneous AT, it was less than half that found in visceral tissue. In 
addition, unlike our study, they did not count the presence of macrophage ‘ring’ aggregates, 
but rather counted the number of nuclei in cells that stained positive for F480.  Thus, there 
are clear differences in the macrophage trafficking pattern between visceral and 
subcutaneous adipose tissue. 
 As for the cytokine/chemokine mRNA expression, the differences between subcutaneous 
and visceral AT gene expression are likely independent of size alone.  Metabolically, it is 
known that visceral and subcutaneous AT are not equivalent. Studies have indicated that 
gene expression differs between fat depots in both rodents and humans [128, 208]. Genes 
involved in inflammation predominate in the visceral adipose tissue depots [239], while 
genes promoting lipid accumulation predominate in the subcutaneous depots [240]. The 
importance of this is underscored by the depot’s location, as excess visceral adipose tissue is 
associated with many of the adverse consequences of obesity, such as coronary artery 
disease, hypertension and type 2 diabetes. Gesta et al. demonstrated that adipocytes isolated 
from different depots retain their unique gene expression, even in culture [208]. Therefore, it 
is likely that the subcutaneous and visceral depots have different regulatory mechanisms for 
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cytokine gene expression that are independent of their microenvironment. In addition, even 
within the visceral depots, there are differences based on location of the AT (as seen by 
chemokine/cytokine mRNA differences between two visceral depots, epididymal and 
retroperitoneal).   
 This study reports for the first time, metabolic changes, liver triacylglycerol 
accumulation, and adipose tissue inflammation in 3 different depots over a 16 week period of 
high fat feeding. A specific time line can be built from our study that demonstrates a distinct 
pattern of metabolic changes and development of inflammation. We found that serum 
glucose levels increased as early as week 2 on the HF diet and liver triacylglycerol, which 
was significantly higher by week 6, resulted in liver steatosis by week 10. Of particular 
importance, we found significant differences between subcutaneous and visceral adipose 
tissue. Although both depots contained adipocytes of similar size, only the visceral adipose 
tissue demonstrated sustained chemokine and cytokine mRNA levels beginning at week 8 on 
the HF diet. In addition, macrophage infiltration occurred after chemokine expression was 
upregulated, and only in visceral tissue.  At this time, it is unclear why the subcutaneous 
tissue is not as susceptible to inflammation as visceral adipose tissue. Further studies are 
needed to elucidate the mechanisms underlying the disparate inflammatory response between 
subcutaneous and visceral adipose tissue in obesity.  
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A. Abstract 
 Obesity in mice is associated with an impaired immune response to influenza virus 
infection. Influenza viruses induce an inflammatory response in the infected respiratory 
mucosa. Because obesity itself results in an inflammatory state, we hypothesized that 
inflammation in the liver and adipose tissues may contribute to the immune dysfunction 
during influenza infection. C57BL/6 weanling mice were fed a LF or HF diet. Body 
composition, serum cytokines, liver TAG, and liver and adipose tissue cytokine and 
chemokine mRNA transcripts were measured. After 22 weeks on the respective diets, the 
mice were intranasally infected with influenza A/PR8/34. Influenza infection induced liver 
TNFα mRNA expression in both lean and obese mice, but only in obese mice were IL-1β, 
IL-6, and MCP-1 induced. Adipose tissue (AT) responded to influenza infection in a depot-
specific manner. Inguinal AT MIP-1α mRNA transcripts increased in both lean and obese 
mice, but IL-1β and IL-6 only increased in obese mice. Gonadal AT IL-1β and MIP-1α 
mRNA transcripts increased in both groups, while IL-6 and MCP-1 transcripts were already 
higher in obese mice prior to infection. Gonadal and retroperitoneal AT TNFα mRNA 
transcripts decreased in lean but not obese mice during infection. Relative to lean mice, obese 
mice had higher retroperitoneal AT IL-1β, IL-6 and MIP-1α mRNA transcripts 3 d post-
infection. During the influenza infection, in obese mice, but not in lean mice, the number of 
macrophages and T cells in the gonadal AT decreased. This study provides evidence 
suggesting that in obesity, the liver and adipose tissue depots may contribute to immune 
dysfunction during influenza virus infection.  
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B. Introduction 
 Obesity is associated with many adverse health consequences, including immune 
dysfunction. Diet-induced obese mice infected with influenza virus have higher mortality and 
increased inflammatory cellular infiltrate in their lungs than their lean counterparts [62]. 
Adipose tissue (AT) of obese animals and humans is associated with a chronic inflammatory 
state that is characterized by increased expression of inflammatory cytokines, chemokines, 
and increased numbers of macrophages and T lymphocytes. Because of the pro-inflammatory 
state of the AT in obese mice, we hypothesized that the AT itself may be contributing to the 
exaggerated inflammatory response following influenza infection. In addition, the liver may 
contribute to the inflammatory state in obesity as increased free fatty acid flux to hepatocytes 
activates IKK-β, resulting in subsequent NFκB-mediated gene transcription of inflammatory 
cytokines such as TNFα, IL-1β, IL-6 and MCP-1 [115].   
 Feeding a high fat diet induces obesity and liver steatosis. Although there are several 
reports about inflammatory gene expression in adipose tissue, there have been fewer reports 
about inflammatory gene expression in livers with steatosis [122, 241]. Inflammation in the 
liver is primarily defined histologically rather than by the presence of biochemical mediators 
of inflammation. Because leukocyte activation and migration are mediated by inflammatory 
cytokines and chemokines, changes in hepatic inflammatory cytokine and chemokine 
expression due to obesity may be important determinants in the outcome of an influenza 
virus infection.  
 Diet-induced obese mice have increased levels of inflammatory cytokines and 
chemokines in their AT. However, the inflammatory profiles among the AT depots differ. 
Compared to the subcutaneous AT, the visceral depots express quantitatively more 
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inflammatory cytokines, chemokines, and also contain more cytotoxic T lymphocytes and 
macrophages. Of the visceral depots, the gonadal AT has been most widely studied, owing to 
its large size and accessible location. In contrast, the retroperitoneal depot has received 
comparatively little attention. Because the individual AT depots display different 
inflammatory and transcriptional profiles, AT distribution, not only between subcutaneous 
and visceral, but also between the visceral gonadal and retroperitoneal depots may have 
important health consequences. Although the pro-inflammatory state of AT has been studied 
by others, there are no reports of the response of AT to infection. 
 Here, we demonstrate that in obese mice, the AT itself may contribute to the immune 
dysfunction during influenza virus infection through increased inflammatory cytokine and 
chemokine gene expression, and alterations in macrophage and T cell chemotaxis. Our study 
raises the question of whether the increased macrophage and T-cell populations of the AT 
contribute to the lung pathology of the influenza-infected obese mice.  
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C. Materials and methods 
 Animals. Four-week old C57BL/6 mice were purchased from Jackson Labs (Bar Harbor, 
ME) and had ad libitum access to food and water. Mice were housed 4 per cage at the 
University of North Carolina Animal Facility, which is fully accredited by the American 
Association for Accreditation of Laboratory Animal Care. Mice were maintained under 
protocols approved by the UNC at Chapel Hill Institutional Animal Care and Use 
Committee. Each experiment used five to eight mice per group on each of the days 
examined.  
 Diets: Weanling mice were fed Purina standard laboratory chow for 4 days. They were 
then randomized to receive either a low-fat (LF) diet or a high-fat (HF) diet for the remainder 
of the study (#D12328 or D12331, Research Diets, New Brunswick, NJ).  
 Body composition. At 2-week intervals for 16 weeks, and prior to infection at 22 weeks, 
mice were weighed and their body composition was analyzed by PIXImus™ densitometer 
(GE Lunar Corporation; Waukesha, WI).  
 Measurement of liver triacylglycerol content. Approximately 100 mg liver tissue was 
homogenized in tissue lysis buffer. Lipids were extracted with 2:1 (v/v) chloroform: 
methanol, and final extracts were dissolved in 3:1:1 (v/v/v) tert-butanol, methanol, Triton X-
100. Triacylglycerol (TAG) concentrations were measured using and enzymatic colorimetric 
assay. Values are expressed as milligrams of TAG per gram of liver tissue. The liver TAG 
portion of experiment was limited to 14 weeks of dietary intervention.  
 Virus and infection. The mouse-adapted strain of Influenza A/Puerto Rico/8/34 
(A/PR/8) was obtained from the American Type Culture Collection (Rockville, MD), and 
was propagated in the allantoic fluid of fertilized hen eggs. Infectious allantoic fluid was 
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collected, clarified by centrifugation, and the viral titer was determined by hemagglutination 
assay (HAU) [242]. After 22 weeks on the diets, mice were anesthetized with an 
intramuscular injection of a ketamine (0.6 mg/kg)/xylazine (0.35 mg/kg) solution and 
infected intranasally with 2 HAU of A/PR8 virus in 0.02 mL PBS. Previous studies in our 
laboratory established that this dose of virus elicits an immune response while causing little 
mortality in infected control mice.  
 Measurement of serum cytokine concentration. At 2-week intervals for 16 weeks, and 
then prior to infection at 22 weeks (0 d), and 3, and 6 d post-infection (p.i.), mice were killed 
by cervical dislocation and blood was collected from a cardiac puncture. Serum was 
separated by centrifugation (2000 x g; 15 min) and stored at –20°C. Serum cytokines were 
measured by 10-plex Antibody Bead Kit (Biosource, Camarillo, CA).  
 Quantitation of liver and adipose tissue cytokine and chemokine mRNA transcripts.  
Liver and adipose tissues from the inguinal, gonadal, and retroperitoneal depots were 
removed at 2-week intervals for 16 weeks, and then prior to infection at 22 weeks (0 d), 3, 
and 6 d p.i. In the inguinal depot, the lymph node was carefully removed and discarded. Total 
RNA from adipose tissue and liver was isolated using the RNeasy Lipid Tissue, and RNeasy 
Mini kits (Qiagen, Valencia, CA), respectively. Reverse transcription was carried out using 
Superscript II First Strand Synthesis kit (Invitrogen, Carlsbad, CA) using oligo (dT) primers. 
Concentrations of mRNA levels for murine TNFα, IL-1β, IL-6, MCP-1, MIP-1α, and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using quantitative 
RT-PCR (qRT-PCR) with fluorescent reporters detected by a Bio-Rad iCycler PCR machine. 
Probes and intron-exon junction spanning primers were designed using Primer Express 1.5 
(Applied Biosystems, Foster City, CA). The mRNA levels for GAPDH were determined for 
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all samples, and the Ct values were analyzed by 2-way ANOVA. Because Ct values did not 
differ by day or diet, GAPDH was used to normalize gene expression.  
 Immunohistochemistry.  Paraformaldehyde-fixed, paraffin-embedded adipose tissues 
were cut in serial 5μm sections, with 2 sections per slide. Sections were deparaffinized, 
rehydrated, and endogenous peroxidases were quenched with 3% H2O2 for 20 min. Antigen 
retrieval was performed using Retrievagen A (BD Pharmingen, San Jose, CA). Endogenous 
biotin was blocked with diluted egg white for 20 min, rinsed with dH2O, and remaining 
avidin was quenched with 5% milk. Non-specific binding was blocked with 10% goat serum 
with 1% BSA in TBS. On each slide, the first section was the negative control and was 
incubated in diluent without the primary antibody. For macrophage identification, the second 
section was incubated with F4/80 antibody (Abcam, Cambridge, MA) overnight at 4°C. For 
T-cell identification, the second tissue section was incubated with CD3 antibody overnight at 
4°C. After washing in TBS, biotinylated goat anti-rat secondary antibody (BD Pharmingen) 
was applied for 30 min, followed by streptavidin-HRP, DAB substrate solution, and then 
counterstained with hematoxylin. DAB-positive cells were counted under 40 x magnification. 
Adipocyte mean cross sectional area was calculated from 5 sections at 20 x magnification by 
Image J software (1.37v.) downloaded from http://rsb.info.nih.gov/ij/. 
Statistical analysis. Statistical analyses were performed using JMP 6© Statistical 
Software (SAS Institute Inc, Cary, NC). Normally distributed data were analyzed by 2-way 
ANOVA with diet and day as main effects. Post-hoc, Student’s t test was used for 
comparison between the dietary groups and Tukey-Kramer HSD was used for comparisons 
among the days. Nonparametric data were analyzed using the Kruskal Wallis test. 
Differences were considered significant at P ≤ 0.05.  
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D. Results 
 High fat feeding induces obesity and liver steatosis. As reported previously [85, 135, 
210], feeding a high fat diet to mice leads to rapid weight gain (Fig. 4.1A). After two weeks, 
mice on the HF diet weighed significantly more than mice on the LF diet, and the difference 
between the two groups increased over time. At week 12, the HF group weighed 20% more 
than the LF group and by week 16 the HF group had gained twice as much weight as the LF 
group. PIXImus™ analysis revealed, as expected, that the weight gain was due to an increase 
in body fat (Fig. 4.1B). By week 8, the mice on the HF diet had gained twice the body fat 
relative to the mice on the LF diet. By week 16, the mice on the HF diet had 3.3 times the fat 
mass compared to the mice on the LF diet. 
 Liver steatosis is associated with obesity and is also associated with metabolic 
disturbances involving inflammation. Liver triacylglycerol (TAG) content increased over 
time in the mice consuming the HF diet (Fig. 4.1C). By week 10, mice on the HF diet had 
over 5% of their liver weight as TAG, indicating steatosis. By week 14, the mice fed the HF 
diet had 4 times more liver TAG than the mice on the LF diet.  
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Figure 4.1: Progressive increase in body weight, body fat, and liver triacylglycerol 
(TAG) during HF feeding.  (A) Body weight (grams) of mice receiving either a LF diet or 
HF diet, n = 12-16. (B) Percent body fat as determined by PIXImus™, n = 6-8. (C) Hepatic 
TAG content expressed as mg of TAG per gram of liver tissue, n = 6-8. Values represent 
mean ± SEM. *p≤0.05; **p≤0.001 of HF relative to LF group by Student’s t test.  
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Because of the development of liver steatosis, we measured gene expression for 
proinflammatory cytokines and chemokines to determine if the TAG accumulation was 
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associated with liver inflammation. Using qRT-PCR, we measured liver transcript levels for 
TNFα, IL-1B, IL-6, MCP-1 and MIP-1α. As shown in Figure 4.2, induction of inflammatory 
cytokines and chemokines was not related to diet, but rather increased in both groups over 
time, likely reflecting an age, not diet, effect.  
 
Figure 4.2: Liver inflammatory cytokine and chemokine gene expression during HF 
feeding. Liver gene expression of (A) TNFα, (B) IL-1β, (C) IL-6, (D) MCP-1, and (E) MIP-
1α in mice receiving either a LF or HF diet. mRNA expression was determined by 
quantitative RT-PCR using total RNA extracted from the liver. Values are normalized to 
GAPDH, and are expressed relative to the mean value at week 0, which was arbitrarily set to 
1. Each data point represents the mean ± SEM, n = 6-8. Two-way ANOVA indicated that 
there was not a main effect of diet. 
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  Increased inflammatory cytokine gene expression in livers of obese mice infected 
with influenza virus. Although obesity itself did not increase inflammatory mRNA cytokine 
production in the liver of the obese mice, infection with influenza virus had a profound 
effect. As shown in Figure 4.3, in the obese mice 6 days after influenza infection, liver 
mRNA transcripts for TNF-α and IL-6 increased 6-fold, and mRNA transcripts for IL-1β 
doubled. Thus, obesity contributed to an increased inflammatory response in the livers of 
influenza-infected mice. 
Figure 4.3: Liver inflammatory cytokine gene expression during influenza A virus 
infection. Liver gene expression of (A) TNFα, (B) IL-1β, and (C) IL-6 were determined by 
quantitative RT-PCR using total RNA extracted from the liver. Values are normalized to 
GAPDH, and are expressed relative to the mean value of lean, uninfected mice (0 d p.i.), 
which was arbitrarily set to 1. *Different from lean at that time; means for a group without a 
common letter differ by Kruskal-Wallis test, P≤ 0.05. n = 6-8.  
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 Increase in proinflammatory cytokines in the serum of influenza infected lean and 
obese mice. In order to determine if obesity influences serum cytokine concentrations during 
an influenza infection, we measured cytokine concentrations 0, 3, and 6 d post-infection 
(p.i.). Interestingly, in lean mice but not in obese mice, serum TNFα increased (Fig. 4.4A). 
Serum IL-6 concentration increased in both lean and obese mice during infection; however, 
the increase was delayed in obese mice (Fig. 4.4C). In contrast, IL-1β concentration 
decreased in obese mice at 6 d p.i. (Fig. 4.4B). Therefore, obesity altered serum cytokine 
concentrations during influenza virus infection.  
Figure 4.4: Serum cytokine concentrations during influenza A virus infection. Serum 
concentrations of (A) TNFα, (B) IL-1β, and (C) IL-6 during influenza virus infection in lean 
and obese mice. Values are the mean (pg/mL) ± SEM. *Different from lean at that time; 
means for a group without a common letter differ by Kruskal-Wallis test, P≤ 0.05. n = 6-8. 
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 Infection with influenza virus alters the adipose tissue mRNA proinflammatory 
patterns in both lean and obese animals. In our previous report [62], we demonstrated that 
obese mice infected with influenza virus had higher mortality and an altered immune 
response in the lungs compared with infected lean mice. Because the adipose tissue (AT) 
itself contributes to an inflammatory state in obesity, we examined AT depots to determine if 
infection alters the inflammatory pattern in obese animals. We measured TNFα, IL-1β, IL-6, 
MCP-1 and MIP-1α transcript levels in inguinal, gonadal, and retroperitoneal AT of lean and 
obese mice 0, 3, and 6 d post-infection with influenza virus. 
Inguinal AT: During influenza infection, inguinal AT MIP-1α gene expression 
increased in both lean and obese mice (Fig. 4.5E). TNFα and MCP-1 gene expression did not 
change due to influenza infection (Fig. 4.5A and D, respectively). However, in obese mice, 
but not in lean mice, mRNA transcripts for IL-1β and IL-6 also increased (Fig. 4.5B and C, 
respectively). Thus, during influenza infection, obesity increased the inflammatory state in 
the inguinal AT.  
Gonadal AT:  Gonadal IL-6 and MCP-1 gene expression were higher in obese mice 
than lean mice (Fig. 4.5H and I, respectively). TNFα decreased in the lean mice during 
influenza infection, such that at 6 d p.i., TNFα transcripts in the lean mice were lower than in 
obese mice (Fig. 4.5F). IL-1β and MIP-1α mRNA transcripts increased in both groups during 
infection (Fig. 4.5G and J, respectively). Therefore, the overall inflammatory milieu in 
gonadal AT was greater in obese mice than in lean mice during influenza infection.  
Retroperitoneal AT: Retroperitoneal TNFα mRNA decreased in the lean mice, but 
not in the obese mice during infection (Fig. 4.5K). At 3 d p.i., IL-1β, IL-6, and MIP-1α were 
higher in obese mice than in lean mice (Figs. 4.5L, M, and O).  Hence, during influenza 
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infection, the retroperitoneal AT of obese mice had a greater proinflammatory state 
compared to the same AT depot lean mice. 
Figure 4.5: Adipose tissue inflammatory gene expression during influenza A virus 
infection. During influenza virus infection, inguinal, gonadal and retroperitoneal ATs were 
analyzed for TNFα, IL-1β, IL-6, MCP-1, and MIP-1α gene expression. Gene expression was 
determined by quantitative RT-PCR using total RNA extracted from the AT. Values are 
normalized to GAPDH, and are expressed relative to the mean value of lean, uninfected mice 
(0 d p.i.), which was arbitrarily set to 1. *Different from lean at that time; means for a group 
without a common letter differ by Kruskal-Wallis test, P≤ 0.05, n = 5-6. 
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 Macrophage and T-cell- populations in gonadal AT decrease in influenza-infected 
obese mice.  During influenza infection, cells in the respiratory tract express inflammatory 
chemokines and cytokines that attract and activate immune cells in order to fight the 
infecton. Therefore, the differences in the expression of these inflammatory mediators in the 
AT of lean and obese mice may alter the trafficking of immune cells. In order to determine 
whether or not influenza affects the number of macrophages and T lymphocytes in AT of 
lean and obese mice, we calculated their populations in the gonadal AT depot during 
influenza infection. In obese mice infected with influenza, the number of macrophages and T 
cells in the adipose tissue declined (Figs. 4.6A and B, respectively). Therefore, influenza 
infection decreases the number of immune cells in the AT of obese mice.  
 
Figure 4.6: Macrophage and T lymphocyte populations in gonadal AT during influenza 
infection. Gonadal ATs were analyzed for (A) F4/80+ macrophages and (B) CD3+ T 
lymphocytes by immunohistochemistry at 0, 3, and 6 d post influenza infection. Values 
expressed are the mean number of target cells per adipocyte in the entire cross-sectional area 
of the tissue sample, counted at magnification X 40. *Different from lean at that time; means 
for a group without a common letter differ by Kruskal-Wallis test, P≤ 0.05. n = 5. 
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E. Discussion 
 Previously, we demonstrated that relative to lean mice, diet-induced obese mice had a 
worse outcome when infected with influenza virus [62]. In addition, the immune response in 
the lungs of the obese mice was altered. Lately, a great deal of attention has been focused on 
the “chronic inflammation” that occurs in the AT of obese humans and animals [102, 135, 
196, 243-246]. In diet-induced obesity, the AT has been shown to have elevated expression 
of inflammatory genes as well as an influx of macrophages and T cells [120, 121, 124, 135, 
136, 167, 243, 247], which does not occur to the same extent in the AT of lean animals. 
Because the pathology induced by influenza virus infection is primarily due to an 
inflammatory response in the lungs, we reasoned that the AT in obese mice may have an 
exaggerated inflammatory response following influenza virus infection. In addition, because 
TAG accumulates in the liver during high fat feeding, we sought to determine whether a fatty 
liver is associated with increased hepatic inflammatory cytokine and chemokine gene 
expression that may also contribute to immune dysregulation during an influenza virus 
infection. 
 Prior to infection, we first established the metabolic disruptions in mice on the HF diet. 
As reported by others, feeding a high fat diet induces weight gain which results in obesity 
[85, 135, 210]. In agreement with the results of Hong et al., the onset of liver steatosis 
occurred after 10 weeks on the HF diet [119]. However, the increase in TAG accumulation in 
the liver was not associated with increased inflammatory gene expression. Cai et al. reported 
a 3- to 6-fold increase of liver TNFα, IL-1β, and IL6 mRNA levels in diet-induced obese 
mice relative to lean mice [122]. The discrepancy between the results of our study with the 
Cai et al. study may be due to differences in the choice of the control diet. Our study controls 
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consumed a purified LF diet that contains 10% fat. In contrast, the study controls used by Cai 
et al. consumed a chow diet which normally contains 4% fat. Another possible study design 
difference is the age of the animals, as Cai et al. did not specify this. Because age affects 
gene expression in the liver [248], if older mice were used by Cai et al., they may have 
elevated inflammatory transcript levels. During our study, liver MCP-1 mRNA levels did not 
increase. However, Ito et al. reported increased liver MCP-1 mRNA levels in mice that 
consumed a HF diet for 50 weeks [241]. Differences in duration between the studies (16 and 
22 weeks vs. 50 weeks) and therefore, age and extent of obesity, may account for the 
discrepant results. Few studies have investigated liver MIP-1α levels in obesity. In humans, 
liver MIP-1α mRNA levels were increased in individuals with liver steatosis, compared to 
those with normal liver TAG levels [249]. To our knowledge, in mice with liver steatosis or 
diet-induced obesity, liver MIP-1α mRNA levels have not previously been reported. In 
summary, although the livers of mice fed the HF diet had 4 times the TAG content relative to 
mice fed the LF diet, this degree of steatosis did not increase inflammatory gene expression 
in the liver.  
 During influenza A virus infection, the livers of obese mice had inflammatory changes. 
TNFα mRNA levels increased in the livers of both lean and obese influenza-infected mice. 
However, in obese mice, but not in lean mice, liver transcripts of IL-1β and IL-6 increased 
during influenza infection. Compared to lean mice that had been infected with influenza virus 
for 6 d, the livers in obese mice had higher transcript levels of MCP-1. MCP-1 is important 
in clearing influenza virus infection [250, 251]. MCP-1 acts as a chemoattractant for 
leukocytes, including activated T cells and NK cells. During influenza infection, the obese 
mice had fewer NK cells in the lungs [62], raising the question of whether increased liver 
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MCP-1 in the obese mice may have directed leukocyte trafficking away from the site of 
infection in the lungs. There is evidence that leukocytes traffic through the liver during 
influenza infection. Polakos et al. demonstrated that antigen-specific CD8+ T cells migrate 
through the liver during influenza infection [252]. In addition to the role of the inflammatory 
chemokine MCP-1, the upregulated inflammatory cytokine gene expression in the livers of 
the infected obese mice may have altered the immune response. The increase in 
inflammatory cytokine transcripts in the liver may have resulted in the subsequent expression 
of molecules involved in adhesion and extravasation. Therefore, the increased inflammatory 
profile in the livers of obese mice may have  contributed to a dysregulated immune response 
to the infection in the lungs.  
 During an influenza virus infection, cytokines expressed by the infected respiratory 
mucosa can enter the circulation to activate a systemic response. While moderate serum 
levels of inflammatory cytokines are beneficial in controlling the viral infection, excess 
levels have been associated with increased mortality. For example, high IL-6 levels are 
associated with increased mortality from pneumonia of all causes [164], and very high levels 
of TNFα may contribute to mortality from influenza virus infection [168]. Although cytokine 
excess may contribute to increased pathology and mortality, the lack of an appropriate 
cytokine response may be equally detrimental. For example, compared to wild type mice, 
mice deficient in IL-1 receptor and IL-1β have higher mortality from influenza virus [169, 
253, 254]. In our study, obese mice differed from lean mice in that their serum TNFα levels 
failed to increase, IL-1β declined and the increase in IL-6 was delayed. For TNFα, and IL-1β, 
this is in contrast to the gene expression in the liver and lungs [62]. TNFα mRNA levels 
increased in the livers and lungs of obese mice during influenza infection without a 
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coincident increase in serum TNFα levels. Similarly, IL-1β mRNA levels increased in the 
livers of infected obese mice without a coincident increase in serum IL-1β levels.  
 Serum cytokine levels are determined not only by their rate of synthesis, but also by 
receptor uptake. The discrepancy between increased gene expression in the lungs and livers 
without a concordant increase in serum levels may be due to increased uptake at the site of 
cytokine synthesis. There is evidence to suggest that increased  cytokine receptor expression 
in the liver may occur in obesity and infection. For example, in obesity-associated steatosis, 
liver IL-1RI mRNA is upregulated [255], while in obese humans whose steatosis has 
progressed to nonalcoholic steatohepatitis, both IL-1RI and TNFRI (p55) are upregulated 
[118, 255]. In our influenza study, the increase in serum IL-6 levels paralleled the increase in 
liver and lung mRNA. IL-6 has been shown to increase liver expression of IL-1RI, and 
TNFRI [256, 257]. Future studies are necessary to determine whether hepatic cytokine 
receptor expression is changed in obesity, and to identify what impact that change has in 
conjunction with alterations in cytokine expression on immune function.   
  Several studies have shown that obese humans and genetic animal models of obesity have 
elevated levels of inflammatory mediators in their serum [222-226]. However, during 16 
weeks of HF feeding, serum TNFα, IL-1β and IL-6 levels were below the detection limits for 
our assays (assay sensitivity for TNFα ≥ 5 pg/mL; IL-1β ≥ 10 pg/mL; IL-6 ≥ 10 pg/mL). 
Serum TNFα levels remained below the detection limits after 22 weeks of HF feeding, while 
serum IL-1β and IL-6 levels were within detection limits but were similar between the lean 
and obese mice. Hong et al. compared the serum TNFα levels between ob/ob and C57BL/6 
diet-induced obese mice [119]. Both ob/ob and DIO mice that consumed a HF diet between 
10 to 20 weeks of age had mean serum TNFa levels of 3.5 pg/mL. Therefore, although the 
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DIO mice in our study consumed the HF diet 6 and 12 weeks longer, serum TNFα did not 
reach the lower detection limit for our assay of 5 pg/mL. Pitombo et al. measured serum 
TNFα, IL-6 and IL-1β in Swiss mice fed either a standard chow or a HF diet [225]. 
Compared to mice consuming the chow diet, Swiss mice on the HF diet had higher serum 
TNFα, IL-1β, and IL-6 concentrations. Serum cytokine levels in the Swiss mice fed either the 
chow or HF diet were an order of magnitude greater than serum cytokine levels reported in 
C57BL/6 mice, therefore the discrepancy in results between the studies may be due to the 
strain of mice being studied. To our knowledge, serum IL-6 levels in DIO C57BL/6 mice 
have not been reported; IL-6 levels in chow fed C57BL/6 mice are approximately 6 
pg/mL[122]. Taken together, these results indicate that unlike obese humans, some strains of 
diet-induced obese mice, and genetically obese mice, diet-induced obese C57BL/6 mice do 
not have elevated inflammatory serum cytokine levels.  
 The chronic, low-grade inflammation associated with obesity is characterized by 
increased expression of inflammatory mediators by the AT. In this report we provide 
evidence to suggest that in obesity, the AT itself contributes to immune dysfunction during 
an infection through increased inflammatory cytokine and chemokine gene expression. While 
we did not expect the influenza infection to increase inflammation in the inguinal AT 
because of this depot’s distance from the lungs and comparatively low metabolic activity and 
cytokine/chemokine expression, not only did influenza increase MIP-1α gene expression, but 
it increased IL-1β and IL-6 levels specifically in the obese mice. Thus, although excess 
subcutaneous AT carries less risk for chronic diseases than visceral AT, it may contribute to 
alterations in immune function during an infection. As previously mentioned, relative to the 
inguinal AT, the visceral AT of obese mice had a higher inflammatory profile before 
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infection. Influenza infection exacerbated this inflammatory profile, especially in the obese 
mice. There has been considerable interest in how much adipose tissue contributes to 
circulating cytokine levels. As with the lungs and livers of these obese mice, the increased 
cytokine expression by the AT probably serves an autocrine function, since serum levels do 
not parallel the increase in gene expression in the AT. In the obese state, adipose tissue not 
only increases its expression of inflammatory mediators, but there is some evidence that it 
also increases its expresion of receptors [258]. More research is necessary to elucidate 
receptor expression in adipose tissue. A mechanism which could account for the discrepancy 
between TNFα gene expression in AT and serum levels is that the membrane bound form of 
TNFα is increased in obesity [258]. Although our study does not determine whether the 
increased inflammation in the AT of obese mice contributes to their poorer outcome during 
influenza infection, it demonstrates that influenza virus infection increases the inflammatory 
milieu in the adipose tissue. This increase in inflammation is especially evident in obese 
mice.   
 Adipose tissues of obese mice have increased populations of macrophages and T cells 
[124, 135, 136]. MCP-1 and MIP-1α attract monocytes and macrophages as well as T 
lymphocytes [116]. During influenza infection, MCP-1 mRNA levels remained constant 
while MIP-1α increased. Interestingly, the number monocytes/macrophages and T 
lymphocytes in the AT did not change in the lean mice, but in the obese mice the number of 
these cells decreased. Smith et al. showed that the obese influenza-infected mice had 
increased cellular infiltrate [62]. Although we did not follow macrophage and T cell 
trafficking in the mice, our study raises the question of whether an exodus of macrophages 
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and T-cells from the adipose tissue of obese mice contributed to their lung pathology during 
influenza infection.  
 This study raises many important questions about the roles being played by the liver and 
adipose tissues during infection in obese individuals. To our knowledge, there are no reports 
about the incidence or severity of influenza A virus infections in obesity. Given the 
prevalence of obesity and the health threat posed by influenza infection, further research is 
necessary to understand the mechanisms involved in the immune dysfunction associated with 
obesity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V 
 
Summary and Concluding Remarks 
A. Introduction 
 This dissertation is composed of two conceptually distinct parts. The common link 
between these two parts is the study of adipocytes and adipose tissue. In the first part of my 
graduate research, because the control of cellular proliferation and differentiation is tightly 
regulated, we sought to determine whether these processes were functionally connected. The 
second part of my graduate research focused on the inflammatory state of adipose tissue in 
obesity. Because adipose tissue expresses inflammatory mediators that may alter the immune 
response, we measured inflammatory cytokine and chemokine gene expression in the 
absence and presence of influenza A virus infection. This chapter summarizes the results of 
these two parts of my research and discusses the implications of the data. 
B. Summary and implications of mechanisms linking preadipocyte proliferation 
 and differentiation     
 
 Adipose tissue plays a critical role in energy storage and metabolism. In adipose tissue, 
preadipocytes have the ability to proliferate, but lack the ability of differentiated adipocytes 
to store large amounts of TAG and participate in insulin-stimulated glucose uptake. Much of 
what we know about cell cycle regulation and adipocyte differentiation has been elucidated 
from clonal cell lines, such as the 3T3-L1 preadipocyte cell line. When contact-inhibited 
3T3-L1 preadipocytes are induced to differentiate, they reenter the cell cycle and undergo 
one to two rounds of proliferation, called mitotic clonal expansion. During the same time, 
they initiate a cascade of transcription factor expression that culminates in the expression of 
genes necessary for terminal differentiation. C/EBPβ plays a key role as an immediate/early 
transcription factor in this cascade. We show that although C/EBPβ is expressed and located 
in the nucleus within 4 h after induction of differentiation, its DNA binding activity is 
inhibited by its interaction with hypophosphorylated Rb. After Rb is phosphorylated at the 
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G1/S checkpoint, Rb and C/EBPβ dissociate. Then, C/EBPβ is able to bind to the C/EBP 
response element on the C/EBPα promoter and activate gene transcription. Therefore, during 
3T3-L1 adipogenesis, the initiation of differentiation is functionally linked to proliferation by 
the interaction between the C/EBPβ and Rb proteins. 
 Rb is a critical regulator of the cell cycle, as cells lacking a functional Rb protein 
frequently fail to control their cellular proliferation and are therefore associated with 
tumorigenesis. C/EBPβ is critical in the differentiation of a number of cell types, including 
adipocytes, hepatocytes, and the mammary gland. Because fully differentiated cells lack the 
ability to proliferate, C/EBPβ has attracted attention as a potential target for constraining 
tissue growth, as in obesity and cancer. In obesity, however, because adipogenesis is a 
normal adaptation to excess calorie intake, attempts to modify obesity by limiting 
adipogenesis are likely to result in ectopic TAG accumulation and cause adverse health 
consequences. In cancer, adenoviral C/EBPβ vectors are being investigated for their ability to 
reactivate the differentiation program in order to stem tumorigenesis. Hence, our in vitro 
studies in 3T3-L1 preadipocytes contribute toward a better understanding of mechanisms that 
may link mitotic clonal expansion and differentiation in other cell types.  
C. Summary and implications of adipose tissue inflammation in obesity in the 
 absence and presence of influenza A virus infection 
 
 Establishing a timeline of events among changes in body composition, hormonal and 
metabolic parameters, liver and adipose tissue inflammation during the accumulation of 
adipose tissue is necessary in order to understand their relationships. Our studies are the first 
to establish a timeline of inflammatory changes that occur during the onset of obesity. 
Studies published previously have reported increased levels of inflammatory mediators 
during obesity. Therefore, critics may argue that our findings are not novel. However, careful 
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review of the literature reveals many gaps. For example, studies demonstrating increased 
levels of inflammatory mediators have frequently been conducted in genetic rodent models of 
obesity. Although evidence supporting a genetic component to the development of obesity is 
overwhelming, the prevalence of these genetic defects is rare in humans compared to the 
prevalence of obesity. Hence, the diet-induced obese mouse model that we used in our 
studies most closely resembles human obesity. Another attribute of our study is that we 
established changes in metabolic and inflammatory parameters over time. Many other studies 
which reported increased inflammation in obesity have been conducted well after obesity has 
been established. These studies fail to elucidate if the increase in inflammatory mediators 
occurs gradually over the course of adipose tissue accumulation, i.e. whether inflammation 
occurs when the animals are merely overweight, or if the inflammatory state occurs only 
after the animals cross the threshold to obesity. Inflammation in adipose tissue has received a 
considerable amount of attention. Studies have demonstrated that in obesity, the adipose 
tissue is characterized by increased gene expression for inflammatory mediators and 
increased macrophage and T lymphocyte infiltration. Relative to the subcutaneous adipose 
tissue, the visceral adipose tissue has higher inflammatory gene expression and one of these 
visceral depots, the gonadal adipose depot, has higher macrophage cell infiltration. Among 
visceral adipose tissue depots, the gonadal adipose tissues (epididymal in males; parametrial 
in females) have been most widely studied. In contrast, the retroperitoneal depot has received 
very little attention. Indeed, inflammation in the murine retroperitoneal depot has not been 
reported. In the retroperitoneal adipose tissue, we are currently investigating macrophage and 
T lymphocyte cell infiltration. Our research demonstrates that in diet-induced obesity, 
compared to the inguinal or gonadal depots, the retroperitoneal adipose tissue has the greatest 
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increase in inflammatory cytokine and chemokine gene expression in male, but not in female 
mice. Although the retroperitoneal adipose depot is small compared to the gonadal adipose 
depot, it may hold important information about gender-specific health risks associated with 
the accumulation of visceral adipose tissue in the upper abdomen.  
 Previous studies in our lab demonstrated that obese mice infected with influenza A virus 
have an impaired immune response and higher mortality relative to their lean counterparts. 
Although others have reported that certain components of the immune system are impaired in 
obesity, we are the first to demonstrate that adipose tissue itself may contribute to the 
impairment. Obese mice have a heightened inflammatory response in adipose tissue depots 
that are distant from the influenza virus infection. Inflammatory cytokines and chemokines 
facilitate and direct leukocyte trafficking. Therefore, increased expression of these mediators 
in the adipose tissue may disrupt trafficking to the lungs. In addition, we demonstrate that in 
obese mice infected with influenza A virus, macrophage and T cell infiltration in the adipose 
tissue decreases at the same time cellular infiltrate increases in the lungs.  
D.  Public health impact of influenza A virus infection in the obese population 
 The threat of influenza epidemics and pandemics is heightened by increased global travel 
and commerce [259]. The spread of influenza infection causes tremendous economic and 
social loss worldwide due to its toll on the morbidity and mortality of the population. 
Therefore, it is imperative that that we study influenza infection in at-risk populations so that 
we better understand and respond to disease threats. Obese individuals may be at risk for 
increased morbidity and mortality than normal-weight individuals. This study demonstrates 
that in obesity, adipose tissue inflammation is associated with immune dysfunction during 
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influenza A virus infection, and emphasizes the need for future research that will enable 
appropriate allocation of preventive measures.  
 Influenza virus infection may result in two concurrent processes that exacerbate 
morbidity and mortality in obese individuals. One process may be an increase in the 
virulence of the virus, while the second process is the dysfunctional immune response of the 
obese host. Given that in the United States alone, 60 million people are obese [1] and 50 
million people are infected with influenza virus each year [143], the potential public health 
impact of influenza virus infection in the obese population is tremendous. 
 Although there are no direct data linking obesity with increased morbidity and mortality 
from influenza A virus infection, there are data that support this hypothesis. Analysis of data 
from NHANES I, II, and III indicates that a BMI greater than or equal to 35 is associated 
with a two-fold increase in the risk of noncancer, non-CVD mortality, which includes, among 
other causes, acute respiratory disease and infection [260]. Although the noncancer, non-
CVD deaths accounted for 39% of the total deaths in 2004, they are often not considered to 
be weight related [260]. Given that obese mice infected with influenza A virus have 
increased mortality relative to lean mice [62], the association between human obesity and 
increased mortality in this category should be elucidated further.  
 In the population, vaccination is an effective strategy for preventing infection when the 
influenza vaccine matches the circulating influenza strain [148]. For example, pneumonia 
and influenza mortality decreased by 26% in the portion of the population that was targeted 
by a large-scale, cost-free influenza vaccination campaign in Brazil, while those not targeted 
by the vaccination campaign did not have a significant decrease in mortality [261]. However, 
vaccination might not be as effective in obese individuals as people of normal weight, 
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because obese individuals have reduced antibody titers to several vaccines [75, 76, 79]. The 
effectiveness of influenza vaccines in obese individuals relative to lean individuals is not 
known. Therefore, future research is needed to determine whether influenza vaccination 
confers adequate protection to obese individuals.  
 Low vaccination rates [261] and obesity [262] disproportionately affect the poor. In 2005, 
20 states tightened Medicaid eligibility criteria, and 21 states reduced the program benefits 
and/or increased cost-sharing, which has resulted in reduced vaccination rates [263]. To 
compound the problem, between 2000 and 2005, the prevalence of severe poverty, defined as 
less than 50% of the federal poverty threshold, increased by nearly 23% [264]. As family 
budgets are strained by the rising cost of health care and insurance, the ability to purchase 
healthy foods is impaired. The apparent paradox of obesity and poverty is because low-cost 
foods provide adequate kilocalories to meet or exceed energy requirements, but lack the 
dietary quality needed to promote optimal health and prevent chronic disease. For example, 
low-cost diets contain more high-carbohydrate, high-fat foods, and less fruits and vegetables, 
and consequently are lower in antioxidants such as vitamin C and beta carotene than the 
average adult diet [262, 265]. Therefore, the current decline in US household income is likely 
to intensify demands on the health care system in both the short and long term, through the 
decline in vaccination rates and the cumulative effect of poor diet and obesity, especially in 
children [264].  
 Our lab has demonstrated that viruses may become more virulent in an oxidatively 
stressed host [75, 76, 79, 266-270]. As previously mentioned, low-cost diets favor the 
consumption of high kilocalorie foods which are lower in antioxidants than the average adult 
diet [262, 265]. Most programs aimed at alleviating food insecurity and hunger have 
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neglected the increasing problem of obesity. Therefore, these programs should be redirected 
to enable low-income families to access a more healthful diet that includes foods high in 
antioxidants, such as fruits and vegetables. Oxidative stress is increased in the obese state 
[271]. While nutrient deficiencies of antioxidants such as vitamin E and selenium increase 
the virulence of several viruses [266-270], it is not known if oxidative stress resulting from 
obesity increases the virulence of influenza A virus. Therefore, additional research is 
required to determine if obesity alters viral genomes. 
 The World Health Organization and the G-8 summit concur that governments will need 
to work together to develop collaborative strategies in confronting shared problems, 
including the spread of infectious diseases across international borders [259]. At present, 
there is a major mismatch between global expenditure on health research and the nature and 
extent of the global mortality: only 5% of the world's health research budget is being spent 
on conditions responsible for 93% of the global mortality [272]. Given the obesity pandemic 
and the high morbidity and mortality not only from annual influenza epidemics, but also the 
potential for a pandemic, research and public health programs designed to mitigate the effects 
of influenza virus infection in the obese population deserve immediate attention. 
E. Concluding remarks and future directions 
 In conclusion, data obtained from experiments in diet-induced mice indicate that 
inflammation in adipose tissue occurs prior to macrophage infiltration, and prior to the 
significant increases of fasting serum leptin and insulin concentration that are associated with 
obesity. Furthermore, inflammation in adipose tissue is gender and depot-specific, with the 
retroperitoneal adipose tissue in male mice demonstrating higher levels of inflammatory gene 
expression than gonadal or inguinal adipose tissues, and more than any of the adipose tissue 
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depots in obese female mice. Because the retroperitoneal adipose depot is very small in the 
lean mice that are used as the control group, future study designs will need to include more 
mice in this group, because both of the retroperitoneal depots are required to obtain a 
sufficient amount of cytokine mRNA for gene expression analysis by qRT-PCR.  
Furthermore, because of the low numbers of infiltrating cells, pooling of the samples will be 
necessary to measure cellular infiltrate by fluorescence-activated cell sorting.  
 During influenza A virus infection, our data suggest that the adipose tissue itself may be 
contributing to the impaired immune response in the obese animals. While we may speculate 
that increased inflammatory mediators in the adipose tissue caused a disruption in leukocyte 
trafficking, additional studies are necessary to confirm or refute this hypothesis.  The F4/80 
protein is expressed in macrophages, but not in adipocytes. Transgenic mice expressing GFP-
tagged F4/80 protein could be developed. Adipose tissue depots from lean and diet-induced 
obese transgenic mice could be transplanted into wild-type mice. After allowing sufficient 
time for post operative recovery, the wild-type mice could then be infected with influenza A 
virus. Lung sections viewed by fluorescence microscopy would show whether or not 
macrophages from the adipose tissue traffic to the lungs during influenza virus infection, and 
whether the trafficking differs between lean and obese mice. Our data demonstrate that 
during influenza virus infection, inflammation in adipose tissue increases, especially in obese 
mice. This is significant because the adipose depots were distant from the site of infection 
(the lungs). It is possible that an infection located close to the adipose tissue depots would 
cause an even greater inflammatory response. For example, the rotavirus infects the epithelial 
cells of the small intestine [273]. Symptoms of fever, vomiting, and diarrhea have been 
attributed to inflammatory cytokines such as TNFα and IL-6 that are produced by infected 
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cells and leukocytes responding to the infection [274]. However, because adipose tissue in 
obesity has increased inflammatory cytokine gene expression and has increased numbers of 
macrophages and T lymphocytes, it is possible that excess adipose tissue may exacerbate the 
symptoms of a rotavirus infection. At the present time, there are no studies that examine 
whether or not there is a relationship between obesity and the severity of a rotavirus 
infection. The first step would be to review the hospital records of case-control studies that 
have investigated rotavirus infection, especially those studies that also measured serum 
cytokine concentration [274], and determine whether severity of illness and/or serum 
cytokine concentration was correlated with BMI. Subsequently, animal studies could be 
designed to elucidate the role that inflammation in adipose tissue plays during the infection.  
 
 109
REFERENCES 
1. Center for Disease Control, National Center for Health Statistics. 2007, Chronic 
Disease Press Office. 
2. Rahmouni K, et al., Obesity-Associated Hypertension: New Insights Into 
Mechanisms. Hypertension, 2005. 45(1): p. 9-14. 
3. Lazar MA, How obesity causes diabetes: not a tall tale. Science, 2005. 307(5708): 
p. 373-5. 
4. Libby P and Theroux P, Pathophysiology of Coronary Artery Disease. 
Circulation, 2005. 111(25): p. 3481-3488. 
5. Nakeeb A, et al., Insulin Resistance Causes Human Gallbladder Dysmotility. 
Journal of Gastrointestinal Surgery, 2006. 10(7): p. 940-949. 
6. Patil SP, et al., Adult Obstructive Sleep Apnea: Pathophysiology and Diagnosis. 
Chest, 2007. 132(1): p. 325-337. 
7. Stephenson GD and Rose DP, Breast Cancer and Obesity: An Update. Nutrition 
and Cancer, 2003. 45(1): p. 1-16. 
8. Bruce WR, Giacca A, and Medline A, Possible Mechanisms Relating Diet and 
Risk of Colon Cancer. Cancer Epidemiol Biomarkers Prev, 2000. 9(12): p. 1271-
1279. 
9. Shepherd PR, et al., Adipose cell hyperplasia and enhanced glucose disposal in 
transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem, 
1993. 268(30): p. 22243-6. 
10. Gnudi L, Shepherd PR, and Kahn BB, Over-expression of GLUT4 selectively in 
adipose tissue in transgenic mice: implications for nutrient partitioning. Proc Nutr 
Soc, 1996. 55(1B): p. 191-9. 
11. Van RL, Bayliss CE, and Roncari DA, Cytological and enzymological 
characterization of adult human adipocyte precursors in culture. J Clin Invest, 
1976. 58(3): p. 699-704. 
 110
12. Zhang JW, et al., Role of CREB in transcriptional regulation of 
CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem, 
2004. 279(6): p. 4471-8. 
13. Tang QQ, Otto TC, and Lane MD, Mitotic clonal expansion: a synchronous 
process required for adipogenesis. PNAS, 2003. 100(1): p. 44-49. 
14. Rosen ED, The transcriptional basis of adipocyte development. Prostaglandins 
Leukot Essent Fatty Acids, 2005. 73(1): p. 31-4. 
15. Farmer SR, Transcriptional control of adipocyte formation. Cell Metab, 2006. 
4(4): p. 263-73. 
16. Otto TC and Lane MD, Adipose development: from stem cell to adipocyte. Crit 
Rev Biochem Mol Biol, 2005. 40(4): p. 229-42. 
17. Rosen ED, et al., PPAR gamma is required for the differentiation of adipose tissue 
in vivo and in vitro. Mol Cell, 1999. 4(4): p. 611-7. 
18. Wu Z, et al., Cross-regulation of C/EBP alpha and PPAR gamma controls the 
transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell, 1999. 
3(2): p. 151-8. 
19. Gray SL, Dalla Nora E, and Vidal-Puig AJ, Mouse models of PPAR-gamma 
deficiency: dissecting PPAR-gamma's role in metabolic homoeostasis. Biochem 
Soc Trans, 2005. 33(Pt 5): p. 1053-8. 
20. Argmann CA, Cock TA, and Auwerx J, Peroxisome proliferator-activated 
receptor gamma: the more the merrier? Eur J Clin Invest, 2005. 35(2): p. 82-92; 
discussion 80. 
21. Jones JR, et al., Deletion of PPARgamma in adipose tissues of mice protects 
against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U 
S A, 2005. 102(17): p. 6207-12. 
22. Wang ND, et al., Impaired energy homeostasis in C/EBP alpha knockout mice. 
Science, 1995. 269(5227): p. 1108-12. 
 111
23. Yang J, et al., Metabolic response of mice to a postnatal ablation of 
CCAAT/enhancer-binding protein alpha. J Biol Chem, 2005. 280(46): p. 38689-99. 
24. Lin FT and Lane MD, CCAAT/enhancer binding protein alpha is sufficient to 
initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A, 
1994. 91(19): p. 8757-61. 
25. Cao Z, Umek RM, and McKnight SL, Regulated expression of three C/EBP 
isoforms during adipose conversion of 3T3-L1 cells. Genes Dev., 1991. 5: p. 1538-
1552. 
26. Yeh WC, et al., Cascade regulation of terminal adipocyte differentiation by three 
members of the C/EBP family of leucine zipper proteins. Genes Devel., 1995. 9(2): 
p. 168-181. 
27. Cornelius P, MacDougald OA, and Lane MD, Regulation of adipocyte 
development. Annu Rev Nutr, 1994. 14: p. 99-129. 
28. Tanaka T, et al., Defective adipocyte differentiation in mice lacking the C/EBPbeta 
and/or C/EBPdelta gene. Embo J, 1997. 16(24): p. 7432-43. 
29. Yamamoto H, et al., Reduced IRS-2 and GLUT4 expression in PPARgamma2-
induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse 
embryonic fibroblasts. J Cell Sci, 2002. 115(Pt 18): p. 3601-7. 
30. Tang QQ and Lane MD, Activation and centromeric localization of 
CCAAT/enhancer-binding proteins during the mitotic clonal expansion of 
adipocyte differentiation. Genes Dev., 1999. 13: p. 2231-2241. 
31. Hamm JK, Park BH, and Farmer SR, A role for C/EBPbeta in regulating 
peroxisome proliferator-activated receptor gamma activity during adipogenesis in 
3T3-L1 preadipocytes. J Biol Chem., 2001. 276(21): p. 18464-71. 
32. Umek RM, Friedman AD, and McKnight SL, CCAAT-enhancer binding protein: 
a component of a differentiation switch. Science, 1991. 251: p. 288-292. 
33. Cowherd RM, Lyle RE, and McGehee Jr RE, Molecular regulation of adipocyte 
differentiation. Semin Cell Dev Biol., 1999. 10(1): p. 3-10. 
 112
34. Prusty D, et al., Activation of MEK/ERK signaling promotes adipogenesis by 
enhancing PPARgamma and C/EBPalpha gene expression during the 
differentiation  of 3T3-L1 preadipocytes. JBC, 2002. 277(48): p. 46226-32. 
35. Lowell BB, PPARgamma: an essential regulator of adipogenesis and modulator of 
fat cell function. Cell, 1999. 99(3): p. 239-42. 
36. Ntambi JM and Young-Cheul K, Adipocyte differentiation and gene expression. J 
Nutr, 2000. 130(12): p. 3122S-3126S. 
37. Chen PL, et al., Retinoblastoma protein directly interacts with and activates the 
transcription factor NF-IL6. PNAS, 1996. 93: p. 465-469. 
38. Charles A, et al., Retinoblastoma protein complexes with C/EBP proteins and 
activates C/EBP-mediated transcription. J Biol Chem., 2001. 83: p. 414-25. 
39. Morris EJ and Dyson NJ, Retinoblastoma protein partners. Adv. Cancer Res., 
2001. 82: p. 1-54. 
40. Kaelin Jr WG, Alterations in G1/S cell-cycle control contributing to 
carcinogenesis. Ann. NY. Acad. Sci, 1997. 833: p. 29-33. 
41. Nevins JR, Transcriptional regulation. A closer look at E2F. Nature, 1992. 
358(6385): p. 375-376. 
42. Nevins JR, E2F: a link between the Rb tumor suppressor protein and viral 
oncoproteins. Science, 1992. 258: p. 424-429. 
43. Magnaghi-Jaulin L, et al., Retinoblastoma protein represses transcription by 
recruiting a histone deacetylase. Nature, 1998. 391: p. 601-5. 
44. Dyson NJ, The regulation of E2F by pRB-family proteins. Genes  & Dev., 1998. 
12(15): p. 2245-2262. 
45. Mulligan G and Jacks T, The retinoblastoma gene family: cousins with 
overlapping interests. Trends Genet., 1998. 14(6): p. 223-229. 
 113
46. Chen PL, et al., Retinoblastoma protein positively regulates terminal adipocyte 
differentiation through direct interaction with C/EBPs. Genes and Development, 
1996. 10: p. 2794-2804. 
47. Cole KA, et al., Rb regulates C/EBPbeta-DNA-binding activity during 3T3-L1 
adipogenesis. Am J Physiol Cell Physiol, 2004. 286(2): p. C349-54. 
48. Falagas ME and Kompoti M, Obesity and infection. Lancet Infect Dis, 2006. 6(7): 
p. 438-46. 
49. Choban PS, et al., Increased incidence of nosocomial infections in obese surgical 
patients. Am Surg., 1995. 61(11): p. 1001-5. 
50. Lofgren M, et al., Postoperative infections and antibiotic prophylaxis for 
hysterectomy in Sweden: a study by the Swedish National Register for Gynecologic 
Surgery. Acta Obstet Gynecol Scand, 2004. 83(12): p. 1202-7. 
51. Olsen MA, et al., Risk factors for surgical site infection in spinal surgery. J 
Neurosurg, 2003. 98(2 Suppl): p. 149-55. 
52. Wimmer C, et al., Predisposing factors for infection in spine surgery: a survey of 
850 spinal procedures. J Spinal Disord, 1998. 11(2): p. 124-8. 
53. Swenne CL, et al., Surgical-site infections within 60 days of coronary artery by-
pass graft surgery. J Hosp Infect, 2004. 57(1): p. 14-24. 
54. Crabtree TD, et al., Multivariate analysis of risk factors for deep and superficial 
sternal infection after coronary artery bypass grafting at a tertiary care medical 
center. Semin Thorac Cardiovasc Surg, 2004. 16(1): p. 53-61. 
55. Lilienfeld DE, et al., Obesity and diabetes as risk factors for postoperative wound 
infections after cardiac surgery. Am J Infect Control, 1988. 16(1): p. 3-6. 
56. Usha Kiran TS, et al., Outcome of pregnancy in a woman with an increased body 
mass index. Bjog, 2005. 112(6): p. 768-72. 
 114
57. Gottschlich M, et al., Significance of obesity on nutritional, immunologic, 
hormonal, and clinical outcome parameters in burns. J Am Diet Assoc, 1993. 
93(11): p. 1261-8. 
58. Baik I, et al., A prospective study of age and lifestyle factors in relation to 
community-acquired pneumonia in US men and women. Arch Intern Med, 2000. 
160(20): p. 3082-8. 
59. Jedrychowski W, et al., Predisposition to acute respiratory infections among 
overweight preadolescent children: an epidemiologic study in Poland. Public 
Health, 1998. 112(3): p. 189-95. 
60. Conge GA, et al., Influence of different types of experimental obesity on resistance 
of the mouse to infection by Salmonella Typhimurium and Klebsiella pneumoniae. 
Ann Nutr Metab, 1988. 32(3): p. 113-20. 
61. Neves RH, et al., Long-term feeding a high-fat diet causes histological and 
parasitological effects on murine schistosomiasis mansoni outcome. Exp Parasitol, 
2007. 115(4): p. 324-32. 
62. Smith AG, et al., Diet-induced obese mice have increased mortality and altered 
immune responses when infected with influenza virus. J Nutr., 2007. 137(5): p. 
1236-43. 
63. Gibson WT, et al., Congenital leptin deficiency due to homozygosity for the 
Delta133G mutation: report of another case and evaluation of response to four 
years of leptin therapy. J Clin Endocrinol Metab, 2004. 89(10): p. 4821-6. 
64. Farooqi IS, et al., Clinical and molecular genetic spectrum of congenital deficiency 
of the leptin receptor. N Engl J Med, 2007. 356(3): p. 237-47. 
65. Wieland CW, et al., Pulmonary Mycobacterium tuberculosis infection in leptin-
deficient ob/ob mice. Int Immunol, 2005. 17(11): p. 1399-408. 
66. Mancuso P, et al., Leptin corrects host defense defects after acute starvation in 
murine pneumococcal pneumonia. Am J Respir Crit Care Med, 2006. 173: p. 
212-18. 
 115
67. Hsu A, et al., Leptin improves pulmonary bacterial clearance and survival in ob/ob 
mice during pneumococcal pneumonia. Clin Exp Immunol, 2007. 150(2): p. 332-9. 
68. Mancuso P, et al., Leptin-deficient mice exhibit impaired host defense in Gram-
negative pneumonia. J Immunol, 2002. 168(8): p. 4018-24. 
69. Ikejima S, et al., Impairment of host resistance to listeria monocytogenes infection 
in liver of db/db and ob/ob mice. Diabetes, 2005. 54: p. 182-89. 
70. Lamas O, Martinez JA, and Marti A, Obesity and immunocompetence. Eur J 
Clin Nutr, 2002. 56(Suppl 3): p. S42-S45. 
71. Marcos A, Nova E, and Montero A, Changes in the immune system are 
conditioned by nutrition. Eur J Clin Nutr, 2003. 57(Suppl 1): p. s66-9. 
72. Bochicchio GV, et al., A time-dependent analysis of intensive care unit pneumonia 
in trauma patients. J Trauma, 2004. 56(2): p. 296-301. 
73. Tanaka S, et al., T lymphopaenia in relation to body mass index and TNF-alpha in 
human obesity: adequate weight reduction can be corrective. Clin Endocrinol 
(Oxf). 2001. 54(3): p. 347-54. 
74. Tanaka S, Inoue S, and Isoda F, Impaired immunity in obesity: suppressed but 
reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord, 1993. 
10(11): p. 631-636. 
75. Hollinger FB, Factors influencing the immune response to hepatitis B vaccine, 
booster dose guidelines, and vaccine protocol recommendations. Am J Med, 1989. 
87(3A): p. 36S-40S. 
76. Weber DJ, et al., Impaired immunogenicity of hepatitis B vaccine in obese persons. 
N Engl J Med, 1986. 314(21): p. 1393. 
77. Roome AJ, et al., Hepatitis B vaccine responsiveness in Connecticut public saffety 
personnel. JAMA, 1993. 270(24): p. 2931-4. 
 116
78. Young MD, et al., Comparison of a triple antigen and a single antigen 
recombinant vaccine for adult hepatitis B vaccination. J Med Virol., 2001. 64(3): 
p. 290-8. 
79. Reuman PD, et al., The effect of age and weight on the response to formalin 
inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine, 1997. 
15(10): p. 1157-1161. 
80. Eliakim A, et al., Reduced tetanus antibody titers in overweight children. 
Autoimmunity, 2006. 39(2): p. 137-41. 
81. Nieman DC, et al., Immune response to obesity and moderate weight loss. Int J 
Obes Relat Metab Disord, 1996. 20(4): p. 353-60. 
82. Loffreda S and Yang SQ, Leptin regulates proinflammatory immune responses. 
FASEB J., 1998. 12: p. 57-65. 
83. Katagiri K, et al., Impaired contact hypersensitivity in diet-induced obese mice. J 
Dermatol Sci, 2007. 46(2): p. 117-26. 
84. Lamas O, Martinez JA, and Marti A, Effects of a beta3-adrenergic agonist on the 
immune response in diet-induced (cafeteria) obese animals. J Physiol Biochem, 
2003. 59(3): p. 183-191. 
85. Mito N, et al., Change of cytokine balance in diet-induced obese mice. 
Metabolism, 2000. 49(10): p. 1295-300. 
86. Otero M, et al., Towards a pro-inflammatory and immunomodulatory emerging 
role of leptin. Rheumatology (Oxford), 2006. 45(8): p. 944-50. 
87. Matarese G, Moschos S, and Mantzoros CS, Leptin in immunology. J Immunol, 
2005. 174(6): p. 3137-42. 
88. La Cava A and Matarese G, The weight of leptin in immunity. Nat Rev Immunol, 
2004. 4(5): p. 371-9. 
89. Lee SW, et al., IL-6 induces long-term protective immunity against a lethal 
challenge of influenza virus. Vaccine, 1999. 17(5): p. 490-6. 
 117
90. Fantuzzi G, et al., Defining the role of T cell-derived leptin in the modulation of 
hepatic or intestinal inflammation in mice. Clin Exp Immunol, 2005. 142(1): p. 
31-8. 
91. Shirshev SV and Orlova EG, Molecular mechanisms of regulation of functional 
activity of mononuclear phagocytes by leptin. Biochemistry (Mosc), 2005. 70(8): p. 
841-7. 
92. Howard JK, et al., Leptin protects mice from starvation-induced lymphoid atrophy 
and increases thymic cellularity in ob/ob mice. J Clin Invest, 1999. 104(8): p. 1051-
9. 
93. Matarese G, Leptin and the immune system: how nutritional status influences the 
immune response. Eur Cytokine Netw, 2000. 11(1): p. 7-14. 
94. Hick RW, et al., Leptin selectively augments thymopoiesis in leptin deficiency and 
lipopolysaccharide-induced thymic atrophy. J Immunol, 2006. 177(1): p. 169-76. 
95. Macia L, et al., Impairment of dendritic cell functionality and steady-state number 
in obese mice. J Immunol, 2006. 177(9): p. 5997-6006. 
96. Visser M, et al., Low-Grade Systemic Inflammation in Overweight Children. 
Pediatrics, 2001. 107(1): p. e13-. 
97. Poitou C, et al., Serum amyloid A: a marker of adiposity-induced low-grade 
inflammation but not of metabolic status. Obesity (Silver Spring), 2006. 14(2): p. 
309-18. 
98. Kim CS, et al., Circulating levels of MCP-1 and IL-8 are elevated in human obese 
subjects and associated with obesity-related parameters. Int J Obes (Lond), 2006. 
30(9): p. 1347-55. 
99. Trayhurn P and Wood IS, Adipokines: inflammation and the pleiotropic role of 
white adipose tissue. Br J Nutrition, 2004. 92: p. 347-355. 
100. Bruun JM, Effects of proinflammatory cytokines and chemokines on leptin 
production in human adipose  tissue in vitro. Mol Cell Endocrinol, 2002. 190: p. 
91-99. 
 118
101. Gerhardt CC, et al., Chemokines control fat accumulation and leptin secretion by 
cultured human adipocytes. Molecular and Cellular Endocrinology, 2001. 175: p. 
81-92. 
102. Ferrante Jr AW, Obesity-induced inflammation: a metabolic dialogue in the 
language of inflammation. J Intern Med, 2007. 262(4): p. 408-14. 
103. Duvnjak M, et al., Pathogenesis and management issues for non-alcoholic fatty 
liver disease. World J Gastroenterol, 2007. 13(34): p. 4539-50. 
104. Falck-Ytter Y, et al., Clinical features and natural history of nonalcoholic 
steatosis syndromes. Semin Liver Dis, 2001. 21(1): p. 17-26. 
105. Angulo P, Treatment of nonalcoholic fatty liver disease. Ann Hepatol, 2002. 1(1): 
p. 12-9. 
106. Abrams GA, et al., Portal fibrosis and hepatic steatosis in morbidly obese subjects: 
A spectrum of nonalcoholic fatty liver disease. Hepatology, 2004. 40(2): p. 475-83. 
107. Brunt EM, Pathology of fatty liver disease. Modern Pathology, 2007. 20: p. S40-8. 
108. Saadeh S, et al., The utility of radiological imaging in nonalcoholic fatty liver 
disease. Gastroenterology, 2002. 123(3): p. 745-50. 
109. Khurram M and Ashraf MM, A clinical and biochemical profile of biopsy-proven 
non-alcoholic Fatty liver disease subjects. J Coll Physicians Surg Pak, 2007. 17(9): 
p. 531-4. 
110. Park JW, et al., Predictors reflecting the pathological severity of non-alcoholic 
fatty liver disease: comprehensive study of clinical and immunohistochemical 
findings in younger Asian patients. J Gastroenterol Hepatol, 2007. 22(4): p. 491-7. 
111. Garcia-Monzon C, et al., Characterization of pathogenic and prognostic factors of 
nonalcoholic steatohepatitis associated with obesity. J Hepatol, 2000. 33(5): p. 716-
24. 
 119
112. Cortez-Pinto H and Camilo ME, Non-alcoholic fatty liver disease/non-alcoholic 
steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res 
Clin Gastroenterol, 2004. 18(6): p. 1089-104. 
113. Day CP and James OF, Steatohepatitis: a tale of two "hits"? Gastroenterology, 
1998. 114(4): p. 842-5. 
114. Day CP, Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol, 2002. 
16(5): p. 663-78. 
115. Boden G, et al., Free fatty acids produce insulin resistance and activate the 
proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes, 2005. 
54(12): p. 3458-65. 
116. Mak TW and Saunders ME, The immune response. 2006, Boston: Elsevier 
Academic Press. 1194. 
117. Haukeland JW, et al., Systemic inflammation in nonalcoholic fatty liver disease is 
characterized by elevated levels of CCL2. J Hepatol, 2006. 44(6): p. 1167-74. 
118. Crespo J, et al., Gene expression of tumor necrosis factor alpha and TNF-
receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology, 2001. 
34(6): p. 1158-63. 
119. Hong F, et al., Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion 
injury in mice with fatty liver disease. Hepatology, 2004. 40(4): p. 933-41. 
120. Kanda H, et al., MCP-1 contributes to macrophage infiltration into adipose tissue, 
insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest., 2006. 116(6): p. 
1494-1505. 
121. Kamei N, et al., Overexpression of monocyte chemoattractant protein-1 in adipose 
tissues causes macrophage recruitment and insulin resistance. J Biol Chem., 2006. 
281(36): p. 26602-14. 
122. Cai D, et al., Local and systemic insulin resistance resulting from hepatic 
activation of IKK-beta and NF-kappaB. Nat Med, 2005. 11(2): p. 183-90. 
 120
123. Arner P, Not all fat is alike. Lancet, 1998. 351(9112): p. 1301-2. 
124. Weisberg SP, et al., Obesity is associated with macrophage accumulation in 
adipose tissue. J Clin Invest., 2003. 112(12): p. 1796-1808. 
125. Okamoto Y, et al., Comparison of mitochondrial and macrophage content between 
subcutaneous and visceral fat in db/db mice. Exp Mol Pathol, 2007. 83(1): p. 73-
83. 
126. Clement K, et al., Weight loss regulates inflammation-related genes in white 
adipose tissue of obese subjects. Faseb J, 2004. 18(14): p. 1657-69. 
127. Bruun JM, et al., Higher production of IL-8 in visceral vs. subcutaneous adipose 
tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol 
Metab, 2004. 286(1): p. E8-13. 
128. Bruun JM, et al., Monocyte chemoattractant protein-1 release is higher in visceral 
than subcutaneous human adipose tissue (AT): implication of macrophages 
resident in the AT. J Clin Endocrinol Metab, 2005. 90(4): p. 2282-9. 
129. Lihn AS, et al., Lower expression of adiponectin mRNA in visceral adipose tissue 
in lean and obese subjects. Mol Cell Endocrinol, 2004. 219(1-2): p. 9-15. 
130. Masuzaki H, et al., Human obese gene expression. Adipocyte-specific expression 
and regional differences in the adipose tissue. Diabetes, 1995. 44(7): p. 855-8. 
131. Van Harmelen V, et al., Leptin secretion from subcutaneous and visceral adipose 
tissue in women. Diabetes, 1998. 47(6): p. 913-7. 
132. Juge-Aubry CE, et al., Adipose tissue is a major source of interleukin-1 receptor 
antagonist: upregulation in obesity and inflammation. Diabetes, 2003. 52(5): p. 
1104-10. 
133. Sbarbati A, et al., Obesity and Inflammation: Evidence for an Elementary Lesion. 
Pediatrics, 2006. 117(1): p. 220-223. 
 121
134. Cinti S, et al., Adipocyte death defines macrophage localization and function in 
adipose tissue of obese mice and humans. J. Lipid Res., 2005. 46(11): p. 2347-
2355. 
135. Xu H, et al., Chronic inflammation in fat plays a crucial role in the development of 
obesity-related insulin resistance. J Clin Invest., 2003. 112(12): p. 1821-1830. 
136. Wu H, et al., T-cell accumulation and regulated on activation, normal T cell 
expressed and secreted upregulation in adipose tissue in obesity. Circulation, 2007. 
115(8): p. 1029-38. 
137. Cancello R, et al., Reduction of macrophage infiltration and chemoattractant gene 
expression changes in white adipose tissue of morbidly obese subjects after surgery-
induced weight loss. Diabetes, 2005. 54(8): p. 2277-86. 
138. Cottam DR, Mattar SG, and Barinas-Mitchell E, The chronic inflammatory 
hypothesis for the morbidity associated with morbid obesity: implications and 
effects of weight loss. Obesity Surgery, 2004. 14: p. 589-600. 
139. Hotamisligil GS, Shargill NS, and Spiegelman BM, Adipose expression of tumor 
necrosis factor-a: direct role in obesity-linked insulin resistance. Science, 1993. 
259: p. 87-91. 
140. Fried SK, Bunkin DA, and Greenberg AS, Omental and subcutaneous adipose 
tissues of obese subjects release interleukin-6:depot difference and regulation by 
glucocorticoid. J. Clin. Endocrinol. Metab., 1998. 83: p. 847-850. 
141. Mohamed-Ali V, et al., Subcutaneous adipose tissue releases interleukin-6, but not 
tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab, 1997. 82(12): p. 4196-
4200. 
142. Kern PA, et al., The expression of tumor necrosis factor in human adipose tissue. 
Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin 
Invest, 1995. 95(5): p. 2111-9. 
143. Center for Disease Control, I., 2005-06 U.S. Influenza Season Summary, in 
Pneumonia and Influenza (P&I) Mortality Surveillance. 2007. 
 122
144. Szucs T, The socio-economic burden of influenza. J Antimicrob Chemother, 1999. 
44 Suppl B: p. 11-5. 
145. Knipe DM and Howley PM, Fields Virology. 5th ed. Vol. 2. 2007: Lippincott, 
Williams and Wilkins. 
146. Bender BS and Small Jr PA, Influenza: pathogenesis and host defense. Semin 
Respir Infect, 1992. 7(1): p. 38-45. 
147. Cox NJ and Subbarao K, Influenza. Lancet, 1999. 354(9186): p. 1277-82. 
148. Janeway CA, et al., Immunobiology. 6 ed, ed. E. Lawrence. 2005, New York: 
Garland Science Publishing. 823. 
149. La Gruta NL, et al., A question of self-preservation: immunopathology in 
influenza virus infection. Immunol Cell Biol, 2007. 85(2): p. 85-92. 
150. Julkunen I, et al., Inflammatory responses in influenza A virus infection. Vaccine, 
2000. 19 Suppl 1: p. S32-7. 
151. Toms GL, et al., The relation of pyrexia and nasal inflammatory response to virus 
levels in nasal washings of ferrets infected with influenza viruses of differing 
virulence. Br J Exp Pathol, 1977. 58(4): p. 444-58. 
152. Shiratsuchi A and Nakanishi Y, [Elimination of influenza virus-infected cells by 
phagocytosis]. Yakugaku Zasshi, 2006. 126(12): p. 1245-51. 
153. Hashimoto Y, et al., Evidence for phagocytosis of influenza virus-infected, 
apoptotic cells by neutrophils and macrophages in mice. J Immunol, 2007. 178(4): 
p. 2448-57. 
154. Brown DM, Roman E, and Swain SL, CD4 T cell responses to influenza infection. 
Semin Immunol, 2004. 16(3): p. 171-7. 
155. Moore BB, Moore TA, and Toews GB, Role of T- and B-lymphocytes in 
pulmonary host defences. Eur Respir J, 2001. 18(5): p. 846-56. 
 123
156. Holland SM, Cytokine therapeutics in infectious diseases, ed. Holland SM. Vol. 1. 
2001, Philadelphia: Lippincott Williams and Wilkins. 343. 
157. Bertagnolli MM, Cytokines and T lymphocytes. 1993, Austin: R.G. Landes 
Company. 115. 
158. Van Reeth K, Cytokines in the pathogenesis of influenza. Vet Microbiol, 2000. 
74(1-2): p. 109-16. 
159. Banks WA, Kastin AJ, and Broadwell RD, Passage of Cytokines across the 
Blood-Brain Barrier. Neuroimmunomodulation, 1995. 2(4): p. 241-8. 
160. Maier SF, et al., The Role of the Vagus Nerve in Cytokine-to-Brain 
Communication. Ann NY Acad Sci, 1998. 840(1): p. 289-300. 
161. Silverman MN, et al., Immune modulation of the Hypothalamic-Pituitary-Adrenal 
(HPA) Axis during viral infection. Viral Immunology, 2005. 18(1): p. 41-78. 
162. Moshage H, Cytokines and the hepatic acute phase response. Journal of 
Pathology, 1999. 181(3): p. 257-66. 
163. Ohara-Imaizumi M, et al., The Cytokine Interleukin-1{beta} Reduces the Docking 
and Fusion of Insulin Granules in Pancreatic {beta}-Cells, Preferentially 
Decreasing the First Phase of Exocytosis. J. Biol. Chem., 2004. 279(40): p. 41271-
41274. 
164. Ortqvist A, et al., Diagnostic and prognostic value of interleukin-6 and C-reactive 
protein in community-acquired pneumonia. Scand J Infect Dis, 1995. 27(5): p. 
457-62. 
165. Somm E, et al., Interleukin-1 receptor antagonist is upregulated during diet-
induced obesity and regulates insulin sensitivity in rodents. Diabetologia, 2006. 49: 
p. 387-93. 
166. Borst SE and Conover CF, High-fat diet induces increased tissue expression of 
TNF-alpha. Life Sci, 2005. 77(17): p. 2156-65. 
 124
167. Lagathu C, et al., Long-term treatment with interleukin-1beta induces insulin 
resistance in murine and human adipocytes. Diabetologia, 2006. 49(9): p. 2162-73. 
168. Peper RL and Van Campen H, Tumor necrosis factor as a mediator of 
inflammation in influenza A viral pneumonia. Microb Pathog, 1995. 19(3): p. 175-
83. 
169. Szretter KJ, et al., Role of host cytokine responses in the pathogenesis of avian 
H5N1 influenza viruses in mice. J Virol, 2007. 81(6): p. 2736-44. 
170. Sijben JW and Calder PC, Differential immunomodulation with long-chain n-3 
PUFA in health and chronic disease. Proc Nutr Soc, 2007. 66(2): p. 237-59. 
171. Wanten GJ and Calder PC, Immune modulation by parenteral lipid emulsions. 
Am J Clin Nutr, 2007. 85(5): p. 1171-84. 
172. Browning LM, n-3 Polyunsaturated fatty acids, inflammation and obesity-related 
disease. Proc Nutr Soc, 2003. 62(2): p. 447-53. 
173. Jellema A, Plat J, and Mensink RP, Weight reduction, but not a moderate intake 
of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in 
obese men during the fasting and postprandial state. Eur J Clin Invest, 2004. 
34(11): p. 766-73. 
174. Chan DC, et al., Effect of atorvastatin and fish oil on plasma high-sensitivity C-
reactive protein concentrations in individuals with visceral obesity. Clin Chem, 
2002. 48(6 Pt 1): p. 877-83. 
175. Anderson M and Fritsche KL, (n-3) Fatty acids and infectious disease resistance. 
J Nutr, 2002. 132(12): p. 3566-76. 
176. Han SN, et al., Effect of hydrogenated and saturated, relative to polyunsaturated, 
fat on immune and inflammatory responses of adults with moderate 
hypercholesterolemia. J Lipid Res, 2002. 43(3): p. 445-52. 
177. Waitzberg DL, et al., Parenteral lipid emulsions and phagocytic systems. Br J 
Nutr, 2002. 87 Suppl 1: p. S49-57. 
 125
178. Yaqoob P and Calder P, Effects of dietary lipid manipulation upon inflammatory 
mediator production by murine macrophages. Cell Immunol, 1995. 163(1): p. 120-
8. 
179. Yaqoob P and Calder P, The effect of dietary lipid manipulation on the production 
of murine T-cell derived cytokines. Biochem Soc Trans, 1995. 23(2): p. 279S. 
180. Wardlaw GM, Perspectives in nutrition. 4th ed. Vol. 1. 1999, New York: 
McGraw-Hill Companies, Inc. 727. 
181. Smyth MJ, Sparks RL, and Wharton W, Proadipocyte cell lines: models of 
cellular proliferation and differentiation. J Cell Sci, 1993. 106( Pt 1): p. 1-9. 
182. Green H and Kehinde O, An established preadipose cell line and its differentiation 
in culture. II. Factors affecting the adipose conversion. Cell, 1975. 5(1): p. 19-27. 
183. Green H and Kehinde O, Spontaneous heritable changes leading to increased 
adipose conversion in 3T3 cells. Cell, 1976. 7(1): p. 105-13. 
184. Green H and Meuth M, An established pre-adipose cell line and its differentiation 
in culture. Cell, 1974. 3(2): p. 127-33. 
185. Hwang CS, et al., Adipocyte differentiation and leptin expression. Annu. Rev. Cell 
Dev. Biol., 1997. 13: p. 231-59. 
186. Patel YM and Lane MD, Role of calpain in adipocyte differentiation. PNAS, 1999. 
96: p. 1279-1284. 
187. MacDougald OA, et al., Insulin regulates transcription of the CCAAT/enhancer 
binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 
adipocytes. J Biol Chem., 1995. 270(2): p. 647-54. 
188. Dignam JD, Lebovitz RM, and Roeder RG, Accurate transcription initiation by 
RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic 
Acids Res., 1983. 11(5): p. 1475-89. 
 126
189. Swick AG, et al., Functional analysis of GC element binding and transcription in 
the hamster dihydrofolate reductase gene promoter. Nucleic Acids Res., 1989. 
17(22): p. 9291-304. 
190. Udvadia AJ, Templeton DJ, and Horowitz JM, Functional interactions between 
the retinoblastoma (Rb) protein and Sp-family members: super-activation by Rb 
requires amino acids necessary for growth suppression. PNAS, 1995. 92. 
191. Patel YM and Lane MD, Mitotic clonal expansion during preadipocyte 
differentiation: calpain-mediated turnover of p27. J Biol Chem, 2000. 275(23): p. 
17653-60. 
192. Tang QQ and Lane MD, Role of C/EBP homologous protein (CHOP-10) in the 
programmed activation of CCAAT/enhancer-binding protein-beta during 
adipogenesis. Proc Natl Acad Sci U S A, 2000. 97(23): p. 12446-50. 
193. Piwien-Pilipuk G, MacDougald OA, and Schwartz JM, Dual regulation of 
phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional 
activation and DNA binding in response to growth hormone. J Biol Chem., 2002. 
277(46): p. 44557-44565. 
194. Williams SC, et al., CRP2 (C/EBPB) contains a bipartite regulatory domain that 
controls transcriptional activation, DNA binding and cell specificity. EMBO J., 
1995. 14(13): p. 3170-3183. 
195. Trayhurn P and Wood IS, Adipose tissue in obesity - an inflammatory issue. 
Endocrinology, 2005. 146(3): p. 1003-5. 
196. Wellen KE and Hotamisligil GS, Obesity-induced inflammatory changes in 
adipose tissue. J Clin Invest., 2003. 112(12): p. 1785-8. 
197. Yudkin JS, et al., C-reactive protein in healthy subjects: associations with obesity, 
insulin resistance, and endothelial dysfunction: a potential role for cytokines 
originating from adipose tissue. Arterioscler Thromb Vasc Biol, 1999. 19: p. 972-
978. 
198. Festa A, et al., The relation of body fat mass and distribution to markers of chronic 
inflammation. Int J Obes Relat Metab Disord, 2001. 25(10): p. 1407-15. 
 127
199. Greenberg AS and Obin MS, Obesity and the role of adipose tissue in 
inflammation and metabolism. Am J Clin Nutr, 2006. 83((supplemental)): p. 
461S-5S. 
200. Tilg H and Moschen AR, Adipocytokines: mediators linking adipose tissue, 
inflammation and immunity. Nat Rev Immunol., 2006. 10: p. 772-83. 
201. Eckel RH, Mechanisms of the components of the metabolic syndrome that 
predispose to diabetes and atherosclerotic CVD. Proc Nutr Soc, 2007. 66(1): p. 82-
95. 
202. Christiansen T, Richelsen B, and Bruun JM, Monocyte chemoattractant protein-1 
is produced in isolated adipocytes, associated with adiposity and reduced after 
weight loss in morbid obese subjects. Int J Obes (Lond), 2005. 29(1): p. 146-50. 
203. Lumeng CN, et al., Increased inflammatory properties of adipose tissue 
macrophages recruited during diet-induced obesity. Diabetes, 2007. 56(1): p. 16-23. 
204. Fain JN, Release of interleukins and other inflammatory cytokines by human 
adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam 
Horm, 2006. 74: p. 443-77. 
205. Takahashi K, et al., Adiposity elevates plasma MCP-1 levels leading to the 
increased CD11b-positive monocytes in mice. J Biol Chem., 2003. 278(47): p. 
46654-46660. 
206. Murdolo G, et al., Monocyte chemoattractant protein-1 (MCP-1) in subcutaneous 
abdominal adipose tissue: characterization of interstitial concentration and 
regulation of gene expression by insulin. J Clin Endocrinol Metab, 2007. 92(7): p. 
268-95. 
207. Boivin A, et al., Regional differences in adipose tissue metabolism in obese men. 
Metabolism, 2007. 56(4): p. 533-40. 
208. Gesta S, et al., Evidence for a role of developmental genes in the origin of obesity 
and body fat distribution. Proc Natl Acad Sci U S A, 2006. 103(17): p. 6676-81. 
209. Goodpaster BH, et al., Obesity, regional body fat distribution, and the metabolic 
syndrome in older men and women. Arch Intern Med, 2005. 165(7): p. 777-83. 
 128
210. Lin S, et al., Development of high fat diet-induced obesity and leptin resistance in 
C57Bl/6J mice. Int J Obes Relat Metab Disord, 2000. 24(5): p. 639-46. 
211. Toye AA, et al., A genetic and physiological study of impaired glucose homeostasis 
control in C57BL/6J mice. Diabetologia, 2005. 48(4): p. 675-86. 
212. Funkat A, et al., Metabolic adaptations of three inbred strains of mice (C57BL/6, 
DBA/2, and 129T2) in response to a high-fat diet. J Nutr., 2004. 134(12): p. 3264-
9. 
213. Palming J, et al., The Expression of NAD(P)H:Quinone Oxidoreductase 1 Is High 
in Human Adipose Tissue, Reduced by Weight Loss, and Correlates with Adiposity, 
Insulin Sensitivity, and Markers of Liver Dysfunction. J Clin Endocrinol Metab, 
2007. 92(6): p. 2346-52. 
214. Jernas M, et al., Separation of human adipocytes by size: hypertrophic fat cells 
display distinct gene expression. FASEB J., 2006. 20(9): p. 1540-2. 
215. Farnier C, et al., Adipocyte functions are modulated by cell size change: potential 
involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab 
Disord., 2003. 27(10): p. 1178-86. 
216. Surwit RS, et al., Differential effects of fat and sucrose on the development of 
obesity and diabetes in C57BL/6J and A/J mice. Metabolism, 1995. 44(5): p. 645-
51. 
217. Almind K and Kahn CR, Genetic determinants of energy expenditure and insulin 
resistance in diet-induced obesity in mice. Diabetes, 2004. 53(12): p. 3274-85. 
218. Yeckel CW, et al., Validation of insulin sensitivity indices from oral glucose 
tolerance test parameters in obese children and adolescents. J Clin Endocrinol 
Metab, 2004. 89(3): p. 1096-101. 
219. Keskin M, et al., Homeostasis model assessment is more reliable than the fasting 
glucose/insulin ratio and quantitative insulin sensitivity check index for assessing 
insulin resistance among obese children and adolescents. Pediatrics, 2005. 115(4): 
p. e500-3. 
 129
220. Gungor N, et al., Validation of surrogate estimates of insulin sensitivity and insulin 
secretion in children and adolescents. J Pediatr, 2004. 144(1): p. 47-55. 
221. Conwell LS, et al., Indexes of insulin resistance and secretion in obese children 
and adolescents: a validation study. Diabetes Care, 2004. 27(2): p. 314-9. 
222. Aygun AD, et al., Proinflammatory cytokines and leptin are increased in serum of 
prepubertal obese children. Mediators Inflamm, 2005. 3: p. 180-3. 
223. Park HS, Park JY, and Yu R, Relationship of obesity and visceral adiposity with 
serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract, 
2005. 69(1): p. 29-35. 
224. Malavazos AE, et al., Proinflammatory cytokines and cardiac abnormalities in 
uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab 
Cardiovasc Dis, 2007. 17(4): p. 294-302. 
225. Pitombo C, et al., Amelioration of diet-induced diabetes mellitus by removal of 
visceral fat. J Endocrinol., 2006. 191(3): p. 699-706. 
226. Yamakawa T, et al., Augmented production of tumor necrosis factor-alpha in 
obese mice. Clin Immunol Immunopathol., 1995. 75(1): p. 51-6. 
227. Chen A, et al., Diet Induction of Monocyte Chemoattractant Protein-1 and its 
Impact on Obesity. Obesity Res, 2005. 13(8): p. 1311-1320. 
228. Good M, et al., TNF and TNF receptor expression and insulin sensitivity in human 
omental and subcutaneous adipose tissue--influence of BMI and adipose 
distribution. Diab Vasc Dis Res, 2006. 3(1): p. 26-33. 
229. Murakami K, et al., High fat intake induces a population of adipocytes to co-
express TLR2 and TNFa in mice with insulin resistance. Biochem Biophys Res 
Commun., 2007. 354: p. 727-34. 
230. Morin CL, et al., High Fat Diets Elevate Adipose Tissue-Derived Tumor Necrosis 
Factor-{alpha} Activity. Endocrinology, 1997. 138(11): p. 4665-4671. 
 130
231. Skurk T, et al., Relationship between adipocyte size and adipokine expression and 
secretion. J Clin Endocrinol Metab, 2006. 
232. Monteiro R, et al., Adipocyte size and liability to cell death. Obes Surg., 2006. 
16(6): p. 804-6. 
233. Pausova Z, From big fat cells to high blood pressure: a pathway to obesity-
associated hypertension. Curr Opin Nephrol Hypertens, 2006. 15(2): p. 173-8. 
234. Furukawa S, et al., Increased oxidative stress in obesity and its impact on 
metabolic syndrome. J Clin Invest., 2004. 114(12): p. 1752-61. 
235. Le Lay S, et al., Cholesterol, a cell size-dependent signal that regulates glucose 
metabolism and gene expression in adipocytes. J Biol Chem., 2001. 276(20): p. 
16904-10. 
236. Craig BW, Garthwaite SM, and Holloszy JO, Adipocyte insulin resistance: effects 
of aging, obesity, exercise, and food restriction. J Appl Physiol., 1987. 62(1): p. 95-
100. 
237. Li J, et al., Gene expression profile of rat adipose tissue at the onset of high-fat-diet 
obesity. Am J Physiol Endocrinol Metab., 2002. 282(6): p. E1334-41. 
238. Lolmede K, et al., Effects of hypoxia on the expression of proangiogenic factors in 
differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord., 2003. 
27(10): p. 1187-95. 
239. Bouloumie A, et al., Role of macrophage tissue infiltration in metabolic diseases. 
Curr Opin Clin Nutr Metab Care, 2005. 8(4): p. 347-54. 
240. Tchkonia T, et al., Fat depot origin affects adipogenesis in primary cultured and 
cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol, 2002. 
282: p. R1286–R1296,. 
241. Ito M, et al., Longitudinal analysis of murine steatohepatitis model induced by 
chronic exposure to high-fat diet. Hepatol Res, 2007. 37(1): p. 50-7. 
 131
242. Dowdle W and Schild G, Laboratory propagation of human influenza viruses, 
experimental host range, and isolation from clinical maerial. 1975, Orlando: 
Academic Press. 
243. Nomiyama T, et al., Osteopontin mediates obesity-induced adipose tissue 
macrophage infiltration and insulin resistance in mice. J Clin Invest, 2007. 
117(10): p. 2877-2888. 
244. Maachi M, et al., Systemic low-grade inflammation is related to both circulating 
and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes 
Relat Metab Disord, 2004. 28(8): p. 993-7. 
245. Bastard JP, et al., Recent advances in the relationship between obesity, 
inflammation, and insulin resistance. Eur Cytokine Netw, 2006. 17(1): p. 4-12. 
246. Hotamisligil GS, Inflammatory pathways and insulin action. Int J Obes Relat 
Metab Disord, 2003. 27 Suppl 3: p. S53-5. 
247. Brake DK, et al., ICAM-1 expression in adipose tissue: effects of diet-induced 
obesity in mice. Am J Physiol Cell Physiol, 2006. 291(6): p. C1232-9. 
248. Goto S, et al., Beneficial biochemical outcomes of late-onset dietary restriction in 
rodents. Ann N Y Acad Sci, 2007. 1100: p. 431-41. 
249. Westerbacka J, et al., Genes involved in fatty acid partitioning and binding, 
lipolysis, monocyte/macrophage recruitment and inflammation are overexpressed 
in the human fatty liver of insulin resistant subjects. Diabetes, 2007. 
250. Dessing MC, et al., Monocyte chemoattractant protein 1 contributes to an adequate 
immune response in influenza pneumonia. Clin Immunol, 2007. 
251. Dawson TC, et al., Contrasting effects of CCR5 and CCR2 deficiency in the 
pulmonary inflammatory response to influenza A virus. Am J Pathol, 2000. 156(6): 
p. 1951-9. 
252. Polakos NK, et al., Early intrahepatic accumulation of CD8+ T cells provides a 
source of effectors for nonhepatic immune responses. J Immunol, 2007. 179(1): p. 
201-10. 
 132
253. Schmitz N, et al., Interleukin-1 is responsible for acute lung immunopathology but 
increases survival of respiratory influenza virus infection. J Virol, 2005. 79(10): p. 
6441-8. 
254. Kozak W, et al., Thermal and behavioral effects of lipopolysaccharide and 
influenza in interleukin-1 beta-deficient mice. Am J Physiol Regul Integr Comp 
Physiol, 1995. 269(5): p. R969-977. 
255. Chiappini F, et al., Exploration of global gene expression in human liver steatosis 
by high-density oligonucleotide microarray. Lab Invest, 2006. 86(2): p. 154-65. 
256. Boer U, Fennekohl A, and Puschel GP, Sensitization by interleukin-6 of rat 
hepatocytes to tumor necrosis factor alpha-induced apoptosis. J Hepatol, 2003. 
38(6): p. 728-35. 
257. Ito A, et al., Augmentation of type I IL-1 receptor expression and IL-1 signaling by 
IL-6 and glucocorticoid in murine hepatocytes. J Immunol, 1999. 162(7): p. 4260-
5. 
258. Xu H, et al., Altered tumor necrosis factor-alpha (TNF-alpha) processing in 
adipocytes and increased expression of transmembrane TNF-alpha in obesity. 
Diabetes, 2002. 51(6): p. 1876-83. 
259. Yach D and Bettcher D, The globalization of public health, I: Threats and 
opportunities. Am J Public Health, 1998. 88(5): p. 735-8; discussion 742-4. 
260. Flegal KM, et al., Cause-specific excess deaths associated with underweight, 
overweight, and obesity. Jama, 2007. 298(17): p. 2028-37. 
261. Antunes JL, et al., Effectiveness of influenza vaccination and its impact on health 
inequalities. Int J Epidemiol, 2007. 
262. Tanumihardjo SA, et al., Poverty, obesity, and malnutrition: an international 
perspective recognizing the paradox. J Am Diet Assoc, 2007. 107(11): p. 1966-72. 
263. Molinari NA, et al., Out-of-pocket costs of childhood immunizations: a comparison 
by type of insurance plan. Pediatrics, 2007. 120(5): p. e1148-56. 
 133
 134
264. Woolf SH, Future health consequences of the current decline in US household 
income. Jama, 2007. 298(16): p. 1931-3. 
265. Hampton T, Food insecurity harms health, well-being of millions in the United 
States. Jama, 2007. 298(16): p. 1851-3. 
266. Beck MA and Levander OA, Host nutritional status and its effect on a viral 
pathogen. J Infect Dis, 2000. 182 Suppl 1: p. S93-6. 
267. Beck MA, Nutritionally induced oxidative stress: effect on viral disease. Am J Clin 
Nutr, 2000. 71(6 Suppl): p. 1676S-81S. 
268. Beck MA and Levander OA, Dietary oxidative stress and the potentiation of viral 
infection. Annu Rev Nutr, 1998. 18: p. 93-116. 
269. Beck MA, Rapid genomic evolution of a non-virulent coxsackievirus B3 in 
selenium-deficient mice. Biomed Environ Sci, 1997. 10(2-3): p. 307-15. 
270. Beck MA, Increased virulence of coxsackievirus B3 in mice due to vitamin E or 
selenium deficiency. J Nutr, 1997. 127(5 Suppl): p. 966S-970S. 
271. Vincent HK, Innes KE, and Vincent KR, Oxidative stress and potential 
interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes 
Metab, 2007. 9(6): p. 813-39. 
272. Ijsselmuiden C and Jacobs M, Health research for development: making health 
research work ... for everyone. Scand J Public Health, 2005. 33(5): p. 329-33. 
273. Strauss JH and Strauss EG, Viruses and human disease. 1 ed. Vol. 1. 2002, San 
Diego: Academic Press. 383. 
274. Jiang B, et al., Cytokines as mediators for or effectors against rotavirus disease in 
children. Clin Diagn Lab Immunol, 2003. 10(6): p. 995-1001. 
 
